Companies: 11,345     total market cap: $151.192 T
โ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Helen of Troy
HELE
#6990
Rank
$0.69 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
$29.53
Share price
3.43%
Change (1 day)
49.67%
Change (1 year)
๐Ÿ› Consumer goods
Categories
  1. Helen of Troy
  2. Quarterly Reports (10-Q)
  3. Financial Year FY2027 Q2

Helen of Troy - 10-Q quarterly report FY2027 Q2


Text size:
000091678902/282027Q2FALSEP2Yxbrli:sharesiso4217:USDiso4217:USDxbrli:shareshele:segmentxbrli:pureutr:Ratehele:numberOfInstallmentiso4217:EURiso4217:CADiso4217:GBPiso4217:NOKiso4217:MXN00009167892026-03-012026-08-310000916789dei:OtherAddressMember2026-03-012026-08-3100009167892026-09-2900009167892026-08-3100009167892026-02-2800009167892026-06-012026-08-3100009167892025-06-012025-08-3100009167892025-03-012025-08-310000916789us-gaap:CommonStockMember2025-02-280000916789us-gaap:AdditionalPaidInCapitalMember2025-02-280000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-02-280000916789us-gaap:RetainedEarningsMember2025-02-2800009167892025-02-280000916789us-gaap:RetainedEarningsMember2025-03-012025-05-3100009167892025-03-012025-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-012025-05-310000916789us-gaap:CommonStockMember2025-03-012025-05-310000916789us-gaap:AdditionalPaidInCapitalMember2025-03-012025-05-310000916789us-gaap:CommonStockMember2025-05-310000916789us-gaap:AdditionalPaidInCapitalMember2025-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-05-310000916789us-gaap:RetainedEarningsMember2025-05-3100009167892025-05-310000916789us-gaap:RetainedEarningsMember2025-06-012025-08-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-012025-08-310000916789us-gaap:CommonStockMember2025-06-012025-08-310000916789us-gaap:AdditionalPaidInCapitalMember2025-06-012025-08-310000916789us-gaap:CommonStockMember2025-08-310000916789us-gaap:AdditionalPaidInCapitalMember2025-08-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-08-310000916789us-gaap:RetainedEarningsMember2025-08-3100009167892025-08-310000916789us-gaap:CommonStockMember2026-02-280000916789us-gaap:AdditionalPaidInCapitalMember2026-02-280000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-02-280000916789us-gaap:RetainedEarningsMember2026-02-280000916789us-gaap:RetainedEarningsMember2026-03-012026-05-3100009167892026-03-012026-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-012026-05-310000916789us-gaap:CommonStockMember2026-03-012026-05-310000916789us-gaap:AdditionalPaidInCapitalMember2026-03-012026-05-310000916789us-gaap:CommonStockMember2026-05-310000916789us-gaap:AdditionalPaidInCapitalMember2026-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-05-310000916789us-gaap:RetainedEarningsMember2026-05-3100009167892026-05-310000916789us-gaap:RetainedEarningsMember2026-06-012026-08-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-012026-08-310000916789us-gaap:CommonStockMember2026-06-012026-08-310000916789us-gaap:AdditionalPaidInCapitalMember2026-06-012026-08-310000916789us-gaap:CommonStockMember2026-08-310000916789us-gaap:AdditionalPaidInCapitalMember2026-08-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-08-310000916789us-gaap:RetainedEarningsMember2026-08-310000916789hele:DistributionFacilityInSouthavenMSMemberhele:BeautyWellnessSegmentMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-04-140000916789hele:DistributionFacilityInSouthavenMSMemberhele:BeautyWellnessSegmentMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-04-142026-04-140000916789us-gaap:OperatingSegmentsMember2026-03-012026-08-310000916789hele:HomeOutdoorSegmentMember2025-06-012025-08-310000916789hele:HomeOutdoorSegmentMember2025-03-012025-08-310000916789hele:BeautyWellnessSegmentMember2025-06-012025-08-310000916789hele:BeautyWellnessSegmentMember2025-03-012025-08-310000916789hele:HomeOutdoorMemberhele:HydroFlaskMember2025-06-012025-08-310000916789hele:HomeOutdoorMemberhele:OspreyMember2025-06-012025-08-310000916789hele:HomeOutdoorMemberhele:HydroFlaskMemberus-gaap:TradeNamesMember2025-06-012025-08-310000916789hele:HomeOutdoorMemberhele:OspreyMemberus-gaap:TradeNamesMember2025-06-012025-08-310000916789hele:HomeOutdoorMemberhele:HydroFlaskMember2025-03-012025-08-310000916789hele:HomeOutdoorMemberhele:OspreyMember2025-03-012025-08-310000916789hele:HomeOutdoorMemberhele:HydroFlaskMemberus-gaap:TradeNamesMember2025-03-012025-08-310000916789hele:HomeOutdoorMemberhele:OspreyMemberus-gaap:TradeNamesMember2025-03-012025-08-310000916789hele:HomeOutdoorMemberhele:HydroFlaskMemberus-gaap:CustomerRelationshipsMember2025-03-012025-08-310000916789hele:HomeOutdoorMemberhele:HydroFlaskMemberus-gaap:OtherIntangibleAssetsMember2025-03-012025-08-310000916789hele:BeautyWellnessMemberhele:HealthWellnessMember2025-06-012025-08-310000916789hele:BeautyWellnessMemberhele:DrybarMember2025-06-012025-08-310000916789hele:BeautyWellnessMemberhele:CurlsmithMember2025-06-012025-08-310000916789hele:BeautyWellnessMemberhele:CurlsmithMemberus-gaap:TradeNamesMember2025-06-012025-08-310000916789hele:BeautyWellnessMemberhele:PURReportingUnitMemberus-gaap:TradeNamesMember2025-06-012025-08-310000916789hele:BeautyWellnessMemberhele:DrybarMemberus-gaap:TradeNamesMember2025-06-012025-08-310000916789hele:BeautyWellnessMemberhele:RevlonReportingUnitMemberus-gaap:TrademarksMember2025-06-012025-08-310000916789hele:BeautyWellnessMemberhele:HealthWellnessMember2025-03-012025-08-310000916789hele:BeautyWellnessMemberhele:DrybarMember2025-03-012025-08-310000916789hele:BeautyWellnessMemberhele:CurlsmithMember2025-03-012025-08-310000916789hele:BeautyWellnessMemberhele:CurlsmithMemberus-gaap:TradeNamesMember2025-03-012025-08-310000916789hele:BeautyWellnessMemberhele:PURReportingUnitMemberus-gaap:TradeNamesMember2025-03-012025-08-310000916789hele:BeautyWellnessMemberhele:DrybarMemberus-gaap:TradeNamesMember2025-03-012025-08-310000916789hele:BeautyWellnessMemberhele:RevlonReportingUnitMemberus-gaap:TrademarksMember2025-03-012025-08-310000916789hele:BeautyWellnessMemberhele:DrybarMemberus-gaap:CustomerRelationshipsMember2025-03-012025-08-310000916789hele:BeautyWellnessMemberhele:DrybarMemberus-gaap:OtherIntangibleAssetsMember2025-03-012025-08-310000916789hele:ServiceConditionAwardsMember2026-03-012026-05-310000916789us-gaap:PerformanceSharesMember2026-03-012026-05-310000916789hele:PerformanceConditionSharesMember2026-03-012026-05-310000916789hele:MarketConditionSharesMember2026-03-012026-05-310000916789srt:DirectorMember2026-06-012026-08-310000916789srt:DirectorMember2025-06-012025-08-310000916789srt:DirectorMember2026-03-012026-08-310000916789srt:DirectorMember2025-03-012025-08-310000916789us-gaap:RestrictedStockUnitsRSUMember2026-06-012026-08-310000916789us-gaap:RestrictedStockUnitsRSUMember2025-06-012025-08-310000916789us-gaap:RestrictedStockUnitsRSUMember2026-03-012026-08-310000916789us-gaap:RestrictedStockUnitsRSUMember2025-03-012025-08-310000916789hele:PerformanceBasedAndOtherStockAwardsMember2026-06-012026-08-310000916789hele:PerformanceBasedAndOtherStockAwardsMember2025-06-012025-08-310000916789hele:PerformanceBasedAndOtherStockAwardsMember2026-03-012026-08-310000916789hele:PerformanceBasedAndOtherStockAwardsMember2025-03-012025-08-310000916789hele:MarketConditionSharesMember2026-06-012026-08-310000916789hele:MarketConditionSharesMember2025-06-012025-08-310000916789hele:MarketConditionSharesMember2026-03-012026-08-310000916789hele:MarketConditionSharesMember2025-03-012025-08-310000916789us-gaap:EmployeeStockMember2026-06-012026-08-310000916789us-gaap:EmployeeStockMember2025-06-012025-08-310000916789us-gaap:EmployeeStockMember2026-03-012026-08-310000916789us-gaap:EmployeeStockMember2025-03-012025-08-3100009167892023-03-012024-02-2900009167892024-08-3100009167892024-08-202024-08-200000916789us-gaap:StockCompensationPlanMember2026-06-012026-08-310000916789us-gaap:StockCompensationPlanMember2025-06-012025-08-310000916789us-gaap:StockCompensationPlanMember2026-03-012026-08-310000916789us-gaap:StockCompensationPlanMember2025-03-012025-08-310000916789hele:TalcumPowderLitigationMember2026-06-012026-08-310000916789hele:TalcumPowderLitigationMember2026-03-012026-08-310000916789hele:TalcumPowderLitigationMember2026-08-3100009167892025-03-012026-02-280000916789hele:IEEPATariffRefundMember2026-06-012026-08-310000916789hele:IEEPATariffRefundMember2026-03-012026-08-310000916789us-gaap:PrepaidExpenseAndOtherAssetsCurrenthele:IEEPATariffRefundMember2026-08-310000916789hele:IEEPATariffRefundMember2026-08-310000916789hele:EPAComplianceOfPackagingAndLabelingMember2026-08-252026-08-250000916789hele:EPAComplianceOfPackagingAndLabelingMember2026-02-280000916789us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberhele:CreditAgreementMember2026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberhele:CreditAgreementMember2026-02-280000916789us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberhele:CreditAgreementMember2026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberhele:CreditAgreementMember2026-02-280000916789us-gaap:LineOfCreditMemberhele:CreditAgreementMember2026-08-310000916789us-gaap:LineOfCreditMemberhele:CreditAgreementMember2026-02-280000916789us-gaap:LineOfCreditMember2026-08-310000916789us-gaap:LineOfCreditMember2026-02-280000916789us-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberhele:CreditAgreementWithBankOfAmericaMember2026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2026-08-310000916789us-gaap:SecuredDebtMember2026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:DelayedDrawTermLoanMemberhele:CreditAgreementWithBankOfAmericaMember2026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberhele:DelayedDrawFacilityMember2025-03-012025-08-310000916789us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberhele:DelayedDrawFacilityMember2026-05-310000916789us-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2026-03-012026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberhele:CreditAgreementWithBankOfAmericaMember2026-03-012026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberhele:CreditAgreementWithBankOfAmericaMember2026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:BaseRateMembersrt:MinimumMember2026-03-012026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:BaseRateMembersrt:MaximumMember2026-03-012026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2026-03-012026-08-310000916789us-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2026-03-012026-08-310000916789us-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2026-03-012026-08-310000916789us-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2026-03-012026-08-310000916789us-gaap:LetterOfCreditMembersrt:MinimumMember2026-03-012026-08-310000916789us-gaap:LetterOfCreditMembersrt:MaximumMember2026-03-012026-08-310000916789us-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2026-02-280000916789us-gaap:SecuredOvernightFinancingRateSofrMember2026-08-310000916789us-gaap:SecuredOvernightFinancingRateSofrMember2026-02-280000916789us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMember2026-08-310000916789us-gaap:FairValueInputsLevel2Member2026-08-310000916789us-gaap:FairValueInputsLevel2Member2026-02-280000916789us-gaap:USTreasuryBillSecuritiesMemberus-gaap:FairValueInputsLevel2Member2026-08-310000916789us-gaap:USTreasuryBillSecuritiesMemberus-gaap:FairValueInputsLevel2Member2026-02-280000916789us-gaap:InterestRateSwaptionMemberus-gaap:FairValueInputsLevel2Member2026-08-310000916789us-gaap:InterestRateSwaptionMemberus-gaap:FairValueInputsLevel2Member2026-02-280000916789us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2026-08-310000916789us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2026-02-280000916789us-gaap:USTreasuryBillSecuritiesMember2026-08-310000916789us-gaap:USTreasuryBillSecuritiesMember2026-02-280000916789us-gaap:USTreasuryBillSecuritiesMembersrt:MinimumMember2026-08-310000916789us-gaap:USTreasuryBillSecuritiesMembersrt:MaximumMember2026-08-310000916789us-gaap:USTreasuryBillSecuritiesMember2026-08-310000916789us-gaap:USTreasuryBillSecuritiesMember2026-02-280000916789us-gaap:USTreasuryBillSecuritiesMember2026-06-012026-08-310000916789us-gaap:USTreasuryBillSecuritiesMember2026-03-012026-08-310000916789us-gaap:USTreasuryBillSecuritiesMember2025-06-012025-08-310000916789us-gaap:USTreasuryBillSecuritiesMember2025-03-012025-08-310000916789hele:OliveAndJuneLLCMember2024-12-310000916789hele:OliveAndJuneLLCMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Member2026-08-310000916789hele:OliveAndJuneLLCMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Member2026-02-280000916789hele:OliveAndJuneLLCMemberhele:MeasurementInputAdjustedEBITDAVolatilityRateMemberus-gaap:FairValueInputsLevel3Member2026-08-310000916789hele:OliveAndJuneLLCMemberhele:MeasurementInputAdjustedEBITDAVolatilityRateMemberus-gaap:FairValueInputsLevel3Member2026-02-280000916789hele:OliveAndJuneLLCMemberhele:MeasurementInputCreditRiskDiscountMemberus-gaap:FairValueInputsLevel3Member2026-08-310000916789hele:OliveAndJuneLLCMemberhele:MeasurementInputCreditRiskDiscountMemberus-gaap:FairValueInputsLevel3Member2026-02-280000916789us-gaap:FairValueInputsLevel3Member2026-05-310000916789us-gaap:FairValueInputsLevel3Member2025-05-310000916789us-gaap:FairValueInputsLevel3Member2026-02-280000916789us-gaap:FairValueInputsLevel3Member2025-02-280000916789us-gaap:FairValueInputsLevel3Member2026-06-012026-08-310000916789us-gaap:FairValueInputsLevel3Member2025-06-012025-08-310000916789us-gaap:FairValueInputsLevel3Member2026-03-012026-08-310000916789us-gaap:FairValueInputsLevel3Member2025-03-012025-08-310000916789us-gaap:FairValueInputsLevel3Member2026-08-310000916789us-gaap:FairValueInputsLevel3Member2025-08-310000916789hele:OliveAndJuneLLCMember2025-02-280000916789hele:OliveAndJuneLLCMember2025-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMemberhele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMember2026-06-012026-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMemberhele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMember2026-03-012026-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMemberhele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMember2025-06-012025-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMemberhele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMember2025-03-012025-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:ShortMember2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:EUR2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:EUR2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:EUR2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:EUR2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:CAD2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:CAD2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:CAD2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:CAD2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:GBP2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:GBP2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:GBP2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:GBP2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:NOK2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:NOK2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:NOK2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:NOK2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:MXN2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:MXN2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:MXN2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:MXN2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:MXN2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:InterestRateSwapMember2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:InterestRateSwapMember2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:InterestRateSwapMember2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:InterestRateSwapMember2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrent2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrent2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrent2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrent2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMember2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMembercurrency:EUR2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMembercurrency:EUR2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMembercurrency:EUR2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMembercurrency:EUR2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMembercurrency:GBP2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMembercurrency:GBP2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMembercurrency:GBP2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMembercurrency:GBP2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrent2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:OtherAssetsNoncurrent2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesCurrent2026-08-310000916789us-gaap:NondesignatedMemberus-gaap:OtherLiabilitiesNoncurrent2026-08-310000916789us-gaap:PrepaidExpenseAndOtherAssetsCurrent2026-08-310000916789us-gaap:OtherAssetsNoncurrent2026-08-310000916789us-gaap:AccruedLiabilitiesCurrent2026-08-310000916789us-gaap:OtherLiabilitiesNoncurrent2026-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:ShortMember2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:EUR2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:EUR2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:EUR2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:EUR2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:CAD2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:CAD2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:CAD2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:CAD2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:GBP2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:GBP2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:GBP2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:GBP2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:NOK2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:NOK2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:NOK2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMemberus-gaap:ShortMembercurrency:NOK2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:InterestRateSwapMember2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrentus-gaap:InterestRateSwapMember2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:InterestRateSwapMember2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:InterestRateSwapMember2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrent2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsNoncurrent2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesCurrent2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesNoncurrent2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMember2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMembercurrency:EUR2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMembercurrency:EUR2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMembercurrency:EUR2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMembercurrency:EUR2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrentus-gaap:ForeignExchangeContractMembercurrency:GBP2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherAssetsNoncurrentus-gaap:ForeignExchangeContractMembercurrency:GBP2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesCurrentus-gaap:ForeignExchangeContractMembercurrency:GBP2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherLiabilitiesNoncurrentus-gaap:ForeignExchangeContractMembercurrency:GBP2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrent2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherAssetsNoncurrent2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesCurrent2026-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherLiabilitiesNoncurrent2026-02-280000916789us-gaap:PrepaidExpenseAndOtherAssetsCurrent2026-02-280000916789us-gaap:OtherAssetsNoncurrent2026-02-280000916789us-gaap:AccruedLiabilitiesCurrent2026-02-280000916789us-gaap:OtherLiabilitiesNoncurrent2026-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2026-03-010000916789us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2026-06-012026-08-310000916789us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2025-06-012025-08-310000916789us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax2026-06-012026-08-310000916789us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax2025-06-012025-08-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2026-06-012026-08-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2025-06-012025-08-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseNonoperating2026-06-012026-08-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseNonoperating2025-06-012025-08-310000916789us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2026-03-012026-08-310000916789us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2025-03-012025-08-310000916789us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax2026-03-012026-08-310000916789us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax2025-03-012025-08-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2026-03-012026-08-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2025-03-012025-08-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseNonoperating2026-03-012026-08-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseNonoperating2025-03-012025-08-310000916789us-gaap:ForeignExchangeForwardMemberus-gaap:SellingGeneralAndAdministrativeExpense2026-06-012026-08-310000916789us-gaap:ForeignExchangeForwardMemberus-gaap:SellingGeneralAndAdministrativeExpense2025-06-012025-08-310000916789us-gaap:ForeignExchangeForwardMemberus-gaap:SellingGeneralAndAdministrativeExpense2026-03-012026-08-310000916789us-gaap:ForeignExchangeForwardMemberus-gaap:SellingGeneralAndAdministrativeExpense2025-03-012025-08-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-02-280000916789us-gaap:AccumulatedTranslationAdjustmentMember2025-02-280000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-03-012025-08-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2025-03-012025-08-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-08-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2025-08-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-02-280000916789us-gaap:AccumulatedTranslationAdjustmentMember2026-02-280000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-03-012026-08-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2026-03-012026-08-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-08-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2026-08-310000916789hele:HomeOutdoorSegmentMemberus-gaap:OperatingSegmentsMember2026-06-012026-08-310000916789hele:BeautyWellnessSegmentMemberus-gaap:OperatingSegmentsMember2026-06-012026-08-310000916789us-gaap:OperatingSegmentsMember2026-06-012026-08-310000916789hele:HomeOutdoorSegmentMemberus-gaap:OperatingSegmentsMember2025-06-012025-08-310000916789hele:BeautyWellnessSegmentMemberus-gaap:OperatingSegmentsMember2025-06-012025-08-310000916789us-gaap:OperatingSegmentsMember2025-06-012025-08-310000916789hele:HomeOutdoorSegmentMemberus-gaap:OperatingSegmentsMember2026-03-012026-08-310000916789hele:BeautyWellnessSegmentMemberus-gaap:OperatingSegmentsMember2026-03-012026-08-310000916789hele:HomeOutdoorSegmentMemberus-gaap:OperatingSegmentsMember2025-03-012025-08-310000916789hele:BeautyWellnessSegmentMemberus-gaap:OperatingSegmentsMember2025-03-012025-08-310000916789us-gaap:OperatingSegmentsMember2025-03-012025-08-310000916789hele:HomeOutdoorSegmentMemberhele:IEEPATariffRefundMember2026-06-012026-08-310000916789hele:HomeOutdoorSegmentMemberhele:IEEPATariffRefundMember2026-03-012026-08-310000916789hele:BeautyWellnessSegmentMemberhele:IEEPATariffRefundMember2026-06-012026-08-310000916789hele:BeautyWellnessSegmentMemberhele:IEEPATariffRefundMember2026-03-012026-08-310000916789country:US2026-06-012026-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2026-06-012026-08-310000916789country:US2025-06-012025-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2025-06-012025-08-310000916789country:US2026-03-012026-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2026-03-012026-08-310000916789country:US2025-03-012025-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2025-03-012025-08-310000916789us-gaap:NonUsMember2026-06-012026-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:NonUsMember2026-06-012026-08-310000916789us-gaap:NonUsMember2025-06-012025-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:NonUsMember2025-06-012025-08-310000916789us-gaap:NonUsMember2026-03-012026-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:NonUsMember2026-03-012026-08-310000916789us-gaap:NonUsMember2025-03-012025-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:NonUsMember2025-03-012025-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2026-06-012026-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2025-06-012025-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2026-03-012026-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2025-03-012025-08-310000916789us-gaap:StockCompensationPlanMember2025-06-012025-08-310000916789us-gaap:StockCompensationPlanMember2025-03-012025-08-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended August 31, 2026
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __ to __
Commission File Number: 001-14669
helenoftroylogoa15.jpg
HELEN OF TROY LIMITED
(Exact name of registrant as specified in its charter)
Bermuda74-2692550
(State or other jurisdiction(I.R.S. Employer
of incorporation or organization)Identification No.)
Richmond House
12 Par-la-Ville Road
Hamilton HM 08, Bermuda
(Address of principal executive offices)
201 E. Main Street, Suite 300
El Paso, Texas 79901
(Registrant’s United States Mailing Address) (Zip Code)
(915) 225-8000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: 
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Shares, $0.10 par value per shareHELEThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).       Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒Accelerated filer☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of September 29, 2026, there were 23,390,635 common shares, $0.10 par value per share, outstanding.


HELEN OF TROY LIMITED AND SUBSIDIARIES
FORM 10-Q
TABLE OF CONTENTS
PAGE 
FINANCIAL INFORMATION
Item 1. 
Financial Statements
2
Note 1 - Basis of Presentation and Related Information
7
Note 2 - New Accounting Pronouncements
8
Note 3 - Gain on Sale of Distribution Facility
8
Note 4 - Accrued Expenses and Other Current Liabilities
8
Note 5 - Goodwill and Intangibles
8
Note 6 - Share-Based Compensation Plans
10
Note 7 - Repurchases of Common Stock
10
Note 8 - Commitments and Contingencies
11
Note 9 - Long-Term Debt
12
Note 10 - Fair Value
14
Note 11 - Financial Instruments and Risk Management
16
Note 12 - Accumulated Other Comprehensive Income (Loss)
19
Note 13 - Segment and Geographic Information
19
Note 14 - Income Taxes
22
Note 15 - Earnings Per Share
23
Item 2. 
Management’s Discussion and Analysis of Financial Condition and Results of Operations
24
Item 3. 
Quantitative and Qualitative Disclosures About Market Risk
50
Item 4. 
Controls and Procedures
50
OTHER INFORMATION
Item 1. 
Legal Proceedings
50
Item 1A. 
Risk Factors
50
Item 2. 
Unregistered Sales of Equity Securities and Use of Proceeds
51
Item 5. 
Other Information
51
Item 6. 
Exhibits
52
53
1

PART I.   FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except shares and par value)August 31, 2026February 28, 2026
Assets
Assets, current:
Cash and cash equivalents$22,583 $18,886 
Receivables, less allowances of $5,858 and $4,923
327,758 361,300 
Inventory480,325 455,812 
Prepaid expenses and other current assets38,511 24,146 
Income taxes receivable7,158 5,375 
Total assets, current876,335 865,519 
Property and equipment, net of accumulated depreciation of $212,632 and $193,622
306,382 308,021 
Goodwill472,281 472,281 
Other intangible assets, net of accumulated amortization of $180,990 and $173,495
365,507 372,850 
Operating lease assets52,677 49,371 
Deferred tax assets, net4,914 4,224 
Assets held for sale
— 23,104 
Other assets18,512 20,178 
Total assets$2,096,608 $2,115,548 
Liabilities and Stockholders’ Equity
Liabilities, current:
Accounts payable$277,955 $256,414 
Accrued expenses and other current liabilities211,212 199,606 
Income taxes payable16,843 23,945 
Long-term debt, current maturities25,000 25,000 
Total liabilities, current531,010 504,965 
Long-term debt, excluding current maturities647,622 755,811 
Lease liabilities, non-current52,826 52,884 
Deferred tax liabilities, net8,894 2,699 
Other liabilities, non-current2,427 992 
Total liabilities1,242,779 1,317,351 
Commitments and contingencies
Stockholders’ equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued
— — 
Common stock, $0.10 par. Authorized 50,000,000 shares; 23,297,388 and 23,077,230 shares issued and outstanding
2,330 2,308 
Additional paid in capital 396,609 384,979 
Accumulated other comprehensive income (loss)1,709 (1,877)
Retained earnings453,181 412,787 
Total stockholders’ equity
853,829 798,197 
Total liabilities and stockholders’ equity
$2,096,608 $2,115,548 

See accompanying notes to condensed consolidated financial statements.
2

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Income (Loss) (Unaudited)

Three Months Ended August 31,Six Months Ended August 31,
(in thousands, except per share data)2026202520262025
Sales revenue, net$440,926 $431,781 $843,041 $803,436 
Cost of goods sold210,803 241,100 428,063 437,744 
Gross profit230,123 190,681 414,978 365,692 
Selling, general and administrative expense (“SG&A”)
204,661 176,999 329,167 344,663 
Asset impairment charges— 326,394 — 740,779 
Restructuring charges2,543 3,005 2,543 3,005 
Operating income (loss)
22,919 (315,717)83,268 (722,755)
Non-operating income, net1,761 249 1,979 557 
Interest expense10,892 14,221 23,135 28,029 
Income (loss) before income tax
13,788 (329,689)62,112 (750,227)
Income tax expense (benefit)9,156 (21,046)21,718 9,134 
Net income (loss)$4,632 $(308,643)$40,394 $(759,361)
Earnings (loss) per share:
Basic$0.20 $(13.44)$1.74 $(33.09)
Diluted 0.19 (13.44)1.69 (33.09)
Weighted average shares used in computing earnings (loss) per share:
Basic23,295 22,959 23,280 22,951 
Diluted24,153 22,959 23,956 22,951 

See accompanying notes to condensed consolidated financial statements.
3

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) 

Three Months Ended August 31,Six Months Ended August 31,
(in thousands)2026202520262025
Net income (loss)$4,632 $(308,643)$40,394 $(759,361)
Other comprehensive income (loss), net of tax:
Cash flow hedge activity - interest rate swaps128 (1,449)1,314 (157)
Cash flow hedge activity - foreign currency contracts454 (534)2,272 (7,582)
Total other comprehensive income (loss), net of tax582 (1,983)3,586 (7,739)
Comprehensive income (loss)$5,214 $(310,626)$43,980 $(767,100)

See accompanying notes to condensed consolidated financial statements.
4

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

Common StockAdditional Paid in CapitalAccumulated Other Comprehensive Income (Loss)Retained Earnings
Total Stockholders’ Equity
(in thousands, including shares)SharesPar
Value
Balances at February 28, 202522,856 $2,286 $367,106 $2,278 $1,311,769 $1,683,439 
Net loss
— — — — (450,718)(450,718)
Other comprehensive loss, net of tax— — — (5,756)— (5,756)
Issuance and settlement of restricted stock75 7 (8)— — (1)
Issuance of common stock related to stock purchase plan39 4 1,753 — — 1,757 
Common stock repurchased and retired(25)(3)(1,328)— — (1,331)
Share-based compensation— — 296 — — 296 
Balances at May 31, 202522,945 $2,294 $367,819 $(3,478)$861,051 $1,227,686 
Net loss
— — — — (308,643)(308,643)
Other comprehensive loss, net of tax— — — (1,983)— (1,983)
Issuance and settlement of restricted stock22 2 (1)— — 1 
Common stock repurchased and retired(5)— (151)— — (151)
Share-based compensation— — 9,372 — — 9,372 
Balances at August 31, 202522,962 $2,296 $377,039 $(5,461)$552,408 $926,282 

Balances at February 28, 202623,077 $2,308 $384,979 $(1,877)$412,787 $798,197 
Net income
— — — — 35,762 35,762 
Other comprehensive income, net of tax— — — 3,004 — 3,004 
Issuance and settlement of restricted stock182 18 (18)— — — 
Issuance of common stock related to stock purchase plan89 9 1,325 — — 1,334 
Common stock repurchased and retired(62)(6)(1,209)— — (1,215)
Share-based compensation— — 6,437 — — 6,437 
Balances at May 31, 202623,286 $2,329 $391,514 $1,127 $448,549 $843,519 
Net income
— — — — 4,632 4,632 
Other comprehensive income, net of tax— — — 582 — 582 
Issuance and settlement of restricted stock13 1 (1)— — — 
Common stock repurchased and retired(2)— (47)— — (47)
Share-based compensation— — 5,143 — — 5,143 
Balances at August 31, 202623,297 $2,330 $396,609 $1,709 $453,181 $853,829 

See accompanying notes to condensed consolidated financial statements.

5

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (Unaudited)
Six Months Ended August 31,
(in thousands)20262025
Cash provided by operating activities:
Net income (loss)$40,394 $(759,361)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization26,397 26,944 
Amortization of financing costs811 764 
Non-cash operating lease expense6,602 4,336 
Provision for credit losses 1,430 342 
Non-cash share-based compensation11,580 9,668 
Asset impairment charges
— 740,779 
Gain on sale of distribution facility (54,854)— 
Gain on the sale or disposal of property and equipment(32)(75)
Deferred income taxes and tax credits4,677 (25,770)
Changes in operating capital, net of effects of acquisition of business:
Receivables31,221 77,353 
Inventory(24,513)(76,278)
Prepaid expenses and other current assets(13,179)(8,006)
Other assets and liabilities, net2,368 (1,756)
Accounts payable22,926 11,723 
Accrued expenses and other current liabilities7,987 26,378 
Accrued income taxes(7,364)20,827 
Net cash provided by operating activities
56,451 47,868 
Cash provided (used) by investing activities:
Capital and intangible asset expenditures(18,111)(24,832)
Net proceeds from business acquired
— 3,880 
Payments for purchases of U.S. Treasury Bills
(1,456)(1,387)
Proceeds from maturities of U.S. Treasury Bills1,321 1,275 
Proceeds from sale of distribution facility78,160 — 
Proceeds from the sale of property and equipment32 89 
Proceeds from promissory note328 — 
Net cash provided (used) by investing activities
60,274 (20,975)
Cash used by financing activities:
Proceeds from revolving loans456,030 317,200 
Repayment of revolving loans(552,530)(583,400)
Proceeds from term loans— 250,000 
Repayment of long-term debt
(12,500)(7,031)
Payment of financing costs— (434)
Payment for contingent consideration(4,100)— 
Proceeds from share issuances under share-based compensation plans1,334 1,757 
Payments for repurchases of common stock(1,262)(1,482)
Net cash used by financing activities
(113,028)(23,390)
Net increase in cash and cash equivalents
3,697 3,503 
Cash and cash equivalents, beginning balance18,886 18,867 
Cash and cash equivalents, ending balance$22,583 $22,370 
Supplemental non-cash investing activity:
Capital expenditures included in accounts payable and accrued expenses
$6,939 $7,953 

See accompanying notes to condensed consolidated financial statements.
6

HELEN OF TROY LIMITED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
August 31, 2026

Note 1 - Basis of Presentation and Related Information

Corporate Overview

The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of August 31, 2026 and February 28, 2026, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2026 (“Form 10-K”), and our other reports on file with the Securities and Exchange Commission (the “SEC”).

When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, which are all wholly-owned. We refer to our common shares, par value $0.10 per share, as “common stock.” References to “fiscal” in connection with a numeric year number denotes our fiscal year ending on the last day of February, during the year number listed. References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to accounting principles generally accepted in the United States of America (the “U.S.”). References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. Our portfolio of brands includes OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive & June, among others. As of August 31, 2026, we operated two reportable segments: Home & Outdoor and Beauty & Wellness.

Our Home & Outdoor segment offers a broad range of outstanding world-class brands that help consumers enjoy everyday living inside their homes and outdoors. Our innovative products for home activities include food preparation and storage, cooking, cleaning, organization and beverage service. Our outdoor performance range, on-the-go food storage and beverageware includes lifestyle hydration products, coolers and food storage solutions, backpacks and travel gear. The Beauty & Wellness segment provides consumers with a broad range of outstanding world-class brands for beauty and wellness. In Beauty, we deliver innovation through products such as hair styling appliances, grooming tools, liquid and aerosol personal care products and nail care solutions that help consumers look and feel more beautiful. In Wellness, we are there when you need us most with highly regarded humidifiers, thermometers, water and air purifiers, heaters and fans.

Our business is seasonal due to different calendar events, holidays and seasonal weather and illness patterns. Our fiscal reporting period ends on the last day in February. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Vietnam, Mexico and the U.S.

7

Principles of Consolidation

The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation.

The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

Note 2 - New Accounting Pronouncements

There have been no changes in the information provided in our Form 10-K.

Note 3 - Gain on Sale of Distribution Facility

On April 14, 2026, we completed the sale of our distribution facility in Southaven, Mississippi for a total sales price of $82.0 million, less costs to sell of $3.8 million. Accordingly, we recognized a gain on the sale of $54.9 million within SG&A during the first quarter of fiscal 2027, which was recognized by our Beauty & Wellness segment. The final related property and equipment totaling $23.3 million, net of accumulated depreciation of $29.4 million, was derecognized from the condensed consolidated balance sheet. We used the proceeds from the sale to repay amounts outstanding under our credit facility.

Note 4 - Accrued Expenses and Other Current Liabilities

A summary of accrued expenses and other current liabilities was as follows:
(in thousands)August 31, 2026February 28, 2026
Accrued compensation, benefits and payroll taxes$34,048 $33,838 
Accrued sales discounts and allowances47,982 44,209 
Accrued sales returns21,108 23,234 
Accrued advertising30,304 25,961 
Other77,770 72,364 
Total accrued expenses and other current liabilities$211,212 $199,606 

Note 5 - Goodwill and Intangibles

We perform annual impairment testing each fiscal year and interim impairment testing, if necessary. We write down any asset deemed to be impaired to its fair value.

During the first six months of fiscal 2027, we did not identify any circumstances or conditions which suggest that the carrying value of our goodwill and other intangible assets might be impaired and did not recognize any asset impairment charges.

During the first and second quarters of fiscal 2026, we concluded that a goodwill impairment triggering event had occurred due to a further sustained decline in our stock price, resulting in our carrying value (excluding long-term debt) exceeding the Company’s total enterprise value (market capitalization plus long-term debt). Additional factors that contributed to these conclusions included downward revisions to our internal forecasts and strategic long-term plans, which reflected the tariff policies in effect and the related macroeconomic environment at the end of our first and second quarters of fiscal 2026, including the corresponding impact on consumer spending and retailer orders. These factors were applicable to all of our reporting units, indefinite-lived trademark licenses and trade names and definite-lived trademark
8

licenses, trade names and certain other intangible assets. Thus, we performed quantitative impairment testing on our goodwill and intangible assets described above during the first and second quarters of fiscal 2026.

We estimate the fair value of our trade names and trademark licenses using the relief from royalty method income approach which is based upon projected future discounted cash flows (“DCF Model”). We estimate the fair value of our customer relationships and lists using the distributor method income approach which is based upon a DCF Model. After adjusting the carrying values of our indefinite-lived and definite-lived intangible assets, the Company completed quantitative impairment testing for goodwill. We estimate the fair value of our reporting units using an income approach based upon projected future discounted cash flows.

Based on the outcome of these assessments, we recognized pre-tax asset impairment charges as follows:
(in thousands)Three Months Ended August 31, 2025Six Months Ended August 31, 2025
Home & Outdoor (1)
$85,537 $304,632 
Beauty & Wellness (2)
240,857 436,147 
Total
$326,394 $740,779 
(1)Asset impairment charges recognized for our Home & Outdoor segment during the three months ended August 31, 2025 included goodwill impairment charges of $41.7 million and $19.8 million related to our Hydro Flask and Osprey reporting units, respectively, and trade name impairment charges of $21.0 million and $3.0 million related to our Osprey and Hydro Flask indefinite-lived trade names, respectively. Asset impairment charges recognized for our Home & Outdoor segment during the six months ended August 31, 2025 included goodwill impairment charges of $115.9 million and $113.1 million related to our Hydro Flask and Osprey reporting units, respectively, trade name impairment charges of $40.0 million and $26.0 million related to our Hydro Flask and Osprey indefinite-lived trade names, respectively, and impairment charges of $8.8 million and $0.8 million related to our Hydro Flask customer relationships and other intangible assets, respectively.
(2)Asset impairment charges recognized for our Beauty & Wellness segment during the three months ended August 31, 2025 included goodwill impairment charges of $159.9 million, $46.8 million and $24.5 million related to our Health & Wellness, Drybar and Curlsmith reporting units, respectively, trade name impairment charges of $3.9 million, $1.0 million, and $1.0 million related to our Curlsmith definite-lived trade name, PUR indefinite-lived trade name and Drybar definite-lived trade name, respectively, and impairment charges of $3.9 million related to our Revlon trademark license. Asset impairment charges recognized for our Beauty & Wellness segment during the six months ended August 31, 2025 included goodwill impairment charges of $189.6 million, $134.1 million and $56.8 million related to our Health & Wellness, Drybar and Curlsmith reporting units, respectively, trade name impairment charges of $7.8 million, $7.0 million and $3.8 million related to our Curlsmith definite-lived trade name, PUR indefinite-lived trade name and Drybar definite-lived trade name, respectively, and impairment charges of $23.5 million, $10.7 million and $2.8 million related to our Revlon trademark license, Drybar customer relationships and Drybar other intangible assets, respectively.

During the first quarter of fiscal 2026, in connection with our annual budgeting and forecasting process, management reduced its forecasts for net sales revenue, gross margin and earnings before interest and taxes to reflect the tariff policies in effect and the related macroeconomic environment at the end of our first quarter of fiscal 2026, including the corresponding impact on consumer spending and retailer orders, as applicable. The revised forecasts also resulted in management selecting lower residual growth rates, which were also reflective of revised long-term industry growth expectations, and royalty rates, as applicable. During the second quarter of fiscal 2026, management further reduced its forecasts for net sales revenue, gross margin and earnings before interest and taxes to reflect the tariff policies in effect and the related macroeconomic environment at the end of our second quarter of fiscal 2026, including the impact on consumer spending, retailer orders and China cross border ecommerce due to a shift to localized distribution, as applicable.

9

Note 6 - Share-Based Compensation Plans

As part of our compensation structure, we grant share-based compensation awards to certain employees and non-employee members of our Board of Directors during the fiscal year. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions. In connection with our annual grant during the first quarter of fiscal 2027, we granted 921,095 service condition awards (“Service Condition Awards”) with a weighted average grant date fair value of $16.47. Additionally, we granted 449,304 performance-based awards during the first quarter of fiscal 2027, of which 299,550 contained performance conditions (“Performance Condition Awards”) and 149,754 contained market conditions (“Market Condition Awards”), with weighted average grant date fair values of $16.47 and $12.35, respectively. Refer to our Form 10-K for further information on the Company’s share-based compensation plans.

We recorded share-based compensation expense in SG&A as follows:
Three Months Ended August 31,Six Months Ended August 31,
(in thousands)20262025
2026
2025 (1)
Directors’ stock compensation
$196 $196 $392 $392 
Service Condition Awards3,544 6,627 7,403 10,568 
Performance Condition Awards716 1,664 1,755 (2,862)
Market Condition Awards687 885 1,525 1,009 
Employee stock purchase plan— — 505 561 
Share-based compensation expense5,143 9,372 11,580 9,668 
Less: income tax benefits
(212)(445)(636)(602)
Share-based compensation expense, net of income tax benefits$4,931 $8,927 $10,944 $9,066 
(1)Share-based compensation expense during the six months ended August 31, 2025 includes a benefit for Performance Condition Awards, as a result of a change in estimate from target achievement to zero percent achievement for Performance Condition Awards granted during fiscal 2024.

Unrecognized Share-Based Compensation Expense

As of August 31, 2026, our total unrecognized share-based compensation for all awards was $21.2 million, which will be recognized over a weighted average amortization period of 2.2 years. The total unrecognized share-based compensation reflects an estimate of target achievement for outstanding Performance Condition Awards granted during both fiscal 2027 and 2026, and a weighted average estimate of 80% of target achievement for outstanding Performance Condition Awards granted during fiscal 2025.

Note 7 - Repurchases of Common Stock

In August 2024, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 20, 2024, for a period of three years, and replaced our former repurchase authorization. As of August 31, 2026, our repurchase authorization allowed for the purchase of $496.8 million of common stock.

Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes and federal withholding taxes due from the share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as repurchases of shares.

10

For the periods presented, there were no common stock open market repurchases. The following table summarizes our share repurchase activity in connection with share-based compensation for the periods shown:
Three Months Ended August 31,Six Months Ended August 31,
(in thousands, except share and per share data)2026202520262025
Common stock received in connection with share-based compensation:
Number of shares1,658 5,279 63,858 29,939 
Aggregate value of shares$47 $151 $1,262 $1,482 
Average price per share$28.35 $28.65 $19.76 $49.50 

Note 8 - Commitments and Contingencies

Legal Matters

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below.

On June 7, 2021, we completed the sale of our North America personal care business to HRB Brands LLC (“HRB Brands”). After the sale, we were named as a defendant in multiple lawsuits related to the use of personal care products previously containing talcum powder, primarily Brut deodorant and Ammens powder sold by our wholly-owned subsidiary, Idelle Labs, Ltd. We tendered indemnification of these cases to HRB Brands, which assumed control of the defense of the claims. After many years, during the fourth quarter of fiscal 2026, HRB Brands asserted that it was contesting the indemnification of these cases and tendered the indemnification back to us. Consequently, in order to protect the Company and its rights and defenses, we began to defend these cases. The Company maintains its position that HRB Brands is obligated to defend and indemnify the Company against these claims and plans to vigorously contest HRB Brands’ position. With respect to the talcum powder cases, we believe we have substantial defenses to the claims. The ultimate outcome of enforcing our indemnification claims against HRB Brands and the litigation relating to the talcum cases is inherently uncertain, and we cannot predict its resolution. During the three and six months ended August 31, 2026, we accrued $4.0 million and $5.3 million, respectively, for potential settlements and legal fees and paid approximately $1.4 million during fiscal 2027 related to these cases. As of August 31, 2026, we had an estimated liability of approximately $5.4 million. We cannot estimate the amount or range of amounts by which the liability may exceed the accrual established because of (i) the inherent difficulty in projecting the number of claims that have not yet been asserted or the time period in which future claims may be asserted, (ii) the complaints nearly always assert claims against multiple defendants where the damages alleged are typically not attributed to individual defendants so that a defendant’s share of liability may turn on the law of joint and several liability, which can vary by state, and (iii) the many factors, developments and inherent uncertainties involved with litigation that could affect the Company’s estimate of the liability.

On June 2, 2026, the Company and certain of its officers were named as defendants in a purported federal securities class action lawsuit filed in the United States District Court for the Western District of Texas. The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b‑5 relating to certain prior disclosures of the Company. The plaintiff seeks to represent a class of shareholders who purchased or otherwise acquired the Company’s common stock between April 24, 2024 and October 8, 2025. The Company believes the allegations asserted in the complaint are without merit and intends to defend them vigorously. At this early stage of the proceedings, the Company is unable to predict the outcome of this matter or reasonably estimate the possible loss or range of loss, if any.
11

Tariff Refunds

On March 4, 2026, the U.S. Court of International Trade issued an additional ruling that importers that paid tariffs under International Emergency Economic Powers Act (“IEEPA”) are due refunds and ordered U.S. Customs and Border Protection (“CBP”) to begin the refund process for all importers who were subject to IEEPA duties. During fiscal 2026 and 2027, we paid IEEPA tariffs totaling $80.5 million. On April 20, 2026, CBP launched Phase 1 of a process for submitting IEEPA refund claims, and on June 29, 2026, CBP launched Phase 2 of the IEEPA refund claims process. CBP has established the framework for Phase 3 of the IEEPA refund claims process, and the Company was notified in August 2026 of its eligibility to participate. The Company plans to start filing Phase 3 refund claims after CBP begins accepting submissions. As of August 31, 2026, we collected all our Phase 1 tariff refunds and concluded that our submitted Phase 2 tariff refund claims were probable of being recovered, substantially all of which were approved by CBP prior to August 31, 2026. As a result, during the three and six months ended August 31, 2026, we recognized reductions to “Cost of goods sold” of $26.9 million and $28.7 million, respectively. As of August 31, 2026, our receivable for tariff refunds included within prepaids and other current assets totaled $4.3 million and our reduction to inventory for tariff refunds totaled $0.8 million. During the six months ended August 31, 2026, we collected $25.3 million in tariff refunds. The Company will continue to monitor regulatory guidance regarding the refund process, file additional Phase 2 and Phase 3 claims and recognize additional recoveries when the right to receipt becomes probable.

EPA Regulatory Matter

During fiscal 2022 and 2023, we were in discussions with the U.S. Environmental Protection Agency (the “EPA”) regarding the compliance of packaging and labeling claims on certain of our products in the air and water filtration and humidification categories within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging and labeling compliance discussions, we completed the repackaging and relabeling of impacted products during fiscal 2023. On August 25, 2026, we entered into a final administrative settlement with the EPA related to this matter for $4.4 million, which will be paid in the third quarter of fiscal 2027. As a result, the estimated liability we recognized during fiscal 2026 of $4.4 million remained outstanding as of August 31, 2026. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs.”

Note 9 - Long-Term Debt

A summary of our long-term debt follows:
(in thousands)August 31, 2026February 28, 2026
Credit Agreement (1):
Revolving loans$211,700 $308,200 
Term loans464,844 477,344 
Total borrowings under Credit Agreement676,544 785,544 
Unamortized prepaid financing fees(3,922)(4,733)
Total long-term debt672,622 780,811 
Less: current maturities of long-term debt(25,000)(25,000)
Long-term debt, excluding current maturities$647,622 $755,811 
(1)The weighted average interest rates on borrowings outstanding under the Credit Agreement (defined below) inclusive of the impact of our interest rate swaps as of August 31, 2026 and February 28, 2026 were 5.5% and 5.7%, respectively.

12

Credit Agreement

We have an amended credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for aggregate commitments of $1.25 billion, which are available through (i) a $750 million revolving credit facility, which includes a $50 million sublimit for the issuance of letters of credit, (ii) a $250 million term loan facility, and (iii) a $250 million delayed draw term loan facility. Proceeds can be used for working capital and other general corporate purposes, including funding permitted acquisitions. During the first quarter of fiscal 2026, we borrowed $250.0 million under the delayed draw term loan facility and utilized the proceeds to repay debt outstanding under the revolving credit facility. During the first quarter of fiscal 2026, we capitalized $0.4 million of lender fees and a de minimis amount of third-party fees incurred in connection with the delayed draw term loan facility borrowing, which were recorded as prepaid financing fees in long-term debt. The Credit Agreement matures on February 15, 2029. The Credit Agreement includes an accordion feature, which permits the Company to request to increase its borrowing capacity by an additional $300 million plus an unlimited amount when the Leverage Ratio (as defined in the Credit Agreement), on a pro-forma basis, is less than 3.25 to 1.00. The term loans and delayed draw term loans are currently payable at the end of each fiscal quarter in equal installments of 1.25% of the original principal balance, with the remaining balance due at the maturity date. Borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR (as defined in the Credit Agreement), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.375% and 1.0% to 2.375% for Base Rate and Term SOFR borrowings, respectively. We also incur loan commitment and letter of credit fees under the Credit Agreement ranging from 0.1% to 0.45% per annum and 1.0% to 2.375% per annum, respectively, based on our Net Leverage Ratio.

The floating interest rates on our borrowings under the Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $300 million and $325 million of the outstanding principal balance under the Credit Agreement as of August 31, 2026 and February 28, 2026, respectively. The weighted average interest rate on borrowings hedged with interest rate swaps was 3.3% as of both August 31, 2026 and February 28, 2026. The comparable Term SOFR interest rate as of both August 31, 2026 and February 28, 2026 was 3.7%. See Notes 10, 11, and 12 for additional information regarding our interest rate swaps.

As of August 31, 2026, the balance of outstanding letters of credit was $9.5 million, the amount available for revolving loans under the Credit Agreement was $528.8 million, and the amount available per the maximum Leverage Ratio was $277.3 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As of August 31, 2026, these covenants effectively limited our ability to incur more than $277.3 million of additional debt from all sources, including the Credit Agreement.

Debt Covenants

As of August 31, 2026, we were in compliance with all covenants as defined under the terms of the Credit Agreement.

13

Note 10 - Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques under the accounting guidance related to fair value measurements are based on observable and unobservable inputs. These inputs are classified into the following hierarchy:

Level 1:Quoted prices for identical assets or liabilities in active markets;

Level 2:Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and

Level 3:Unobservable inputs that reflect the reporting entity’s own assumptions.

Recurring Fair Value Measurements

All of our financial assets and liabilities, except for our investments in U.S. Treasury Bills and our contingent consideration liability, are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. Our investments in U.S. Treasury Bills are classified as Level 1 because their value is based on quoted prices in active markets for identical assets. Our contingent consideration liability is classified as Level 3 because its valuation is primarily based on a significant input unobservable in the market, specifically, projected adjusted EBITDA derived from internal forecasts.

The following table presents the fair value of our financial assets and liabilities:
Fair Value
(in thousands)August 31, 2026February 28, 2026
Assets:
Cash equivalents (money market accounts)$3,459 $4,189 
U.S. Treasury Bills
11,166 11,175 
Interest rate swaps1,896 381 
Foreign currency derivatives1,413 375 
Total assets$17,934 $16,120 
Liabilities:
Interest rate swaps$— $196 
Contingent consideration
— 5,400 
Foreign currency derivatives1,312 2,954 
Total liabilities$1,312 $8,550 

All of our financial assets and liabilities, except for our investments in U.S. Treasury Bills, are measured and recorded at fair value on a recurring basis. Our investments in U.S. Treasury Bills are recorded at amortized cost. As of August 31, 2026 and February 28, 2026, the current carrying amounts of our U.S. Treasury Bills were $2.4 million and $2.6 million, respectively, and were included within prepaid expenses and other current assets in our condensed consolidated balance sheets. As of August 31, 2026 and February 28, 2026, the non-current carrying amounts of our U.S. Treasury Bills were $8.9 million and
14

$8.5 million, respectively, and were included within other assets in our condensed consolidated balance sheets.

The carrying amounts of cash and cash equivalents, accounts payable, accrued expenses and other current liabilities and income taxes receivable and payable approximate fair value because of the short maturity of these items. The carrying amounts of receivables approximate fair value due to the effect of the related allowance for credit losses. The carrying amount of our floating rate long-term debt approximates its fair value.

Our investments in U.S. Treasury Bills are classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. We invest in U.S. Treasury Bills with maturities ranging from two to five years. As of August 31, 2026, gross unrealized gains were immaterial and gross unrealized losses were $0.1 million. As of February 28, 2026, gross unrealized gains were $0.1 million and gross unrealized losses were immaterial. During the three and six months ended August 31, 2026, we recognized interest income on these investments of $0.1 million and $0.2 million, respectively, which is included in “Non-operating income, net” in our condensed consolidated statements of income (loss). During the three and six months ended August 31, 2025, we recognized interest income on these investments of $0.1 million and $0.2 million, respectively.

We use foreign currency forward contracts to manage our exposure to changes in foreign currency exchange rates. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. See Notes 11 and 12 for more information on our derivatives.

The purchase consideration for the acquisition of Olive & June in December 2024 included contingent cash consideration of up to $15.0 million payable annually in three equal installments subject to Olive & June achieving certain adjusted EBITDA targets during calendar years 2025, 2026 and 2027. If the annual adjusted EBITDA target is not met, no payment is required. As of the acquisition date, we recorded a liability for the estimated fair value of the contingent consideration of $4.1 million. This contingent consideration liability is remeasured at fair value each reporting period until the contingency is resolved, with changes in fair value recognized in SG&A. The fair value of the contingent consideration liability was determined using a Monte Carlo simulation model, which utilizes projected adjusted EBITDA and corresponding volatility and discount rates to estimate the probability of the adjusted EBITDA targets being achieved. The projected adjusted EBITDA during the earn-out period was derived from internal forecasts and represents a Level 3 input, and was discounted using an estimated discount rate of 14% and 13% as of August 31, 2026 and February 28, 2026, respectively. Adjusted EBITDA volatility was calculated based upon peer companies, and the third quartile of 37% and 41% was selected as a key input into the Monte Carlo simulation model as of August 31, 2026 and February 28, 2026, respectively. In the simulated scenarios where a payment is earned, the projected contingent payments were discounted using an estimated credit risk discount rate of 6.8% and 6.6%, as of August 31, 2026 and February 28, 2026, respectively. Changes in these inputs may result in a significant increase or decrease in the fair value of the contingent consideration liability with a corresponding impact to SG&A.

15

Level 3 Fair Value Measurements

The following table presents the changes in our Level 3 contingent consideration liability:

Three Months Ended August 31,Six Months Ended August 31,
(in thousands)2026202520262025
Balance at beginning of period
$400 $4,100 $5,400 $4,100 
Changes in fair value (1)(400)— (400)— 
Settlements (2)— — (5,000)— 
Balance at end of period (3)$— $4,100 $— $4,100 
(1)Reflects a decrease in the estimated fair value of our contingent consideration liability, which was recognized in SG&A during the three and six months ended August 31, 2026. The fair value of the contingent consideration liability was determined to be de minimis as of August 31, 2026 based on Olive & June’s adjusted EBITDA forecasts and the inputs described above.
(2)Represents a contingent consideration payment of $5.0 million in April 2026 based on Olive & June’s achievement of the adjusted EBITDA target for calendar year 2025.
(3)As of August 31, 2025, the estimated fair value of the contingent consideration liability was $4.1 million, of which $1.8 million was included within accrued expenses and other current liabilities and $2.3 million was included within other liabilities, non-current in our condensed consolidated balance sheet.

Note 11 - Financial Instruments and Risk Management

Foreign Currency Risk

The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales and operating expenses. As a result of such transactions, portions of our cash, accounts receivable and accounts payable are denominated in foreign currencies. Approximately 15% of our net sales revenue was denominated in foreign currencies during both the three and six months ended August 31, 2026, compared to 14% and 15% for the same periods last year, respectively. These sales were primarily denominated in Euros, British Pounds and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases.

In our condensed consolidated statements of income (loss), foreign currency exchange rate gains and losses resulting from the remeasurement of foreign income tax receivables and payables and deferred income tax assets and liabilities are recognized in income tax expense (benefit), and all other foreign currency exchange rate gains and losses are recognized in SG&A. We recorded immaterial foreign currency exchange rate net gains, during both the three and six months ended August 31, 2026, in income tax expense (benefit), compared to net gains of $2.9 million and $9.5 million for the same periods last year, respectively. During the three and six months ended August 31, 2026, we recorded foreign currency exchange rate net losses of $0.1 million and $0.6 million, respectively, in SG&A, compared to net gains of $0.4 million and $2.1 million for the same periods last year, respectively. We mitigate certain foreign currency exchange rate risk by using forward contracts to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Certain of our forward contracts are designated as cash flow hedges (“foreign currency contracts”) and are recorded on the balance sheet at fair value with changes in fair value recorded in Other Comprehensive Income (Loss) (“OCI”) until the hedge transaction is settled, at which point amounts are reclassified from Accumulated Other Comprehensive Income (Loss) (“AOCI”) to our condensed consolidated statements of income
16

(loss). Foreign currency derivatives for which we have not elected hedge accounting consist of certain forward contracts, and any changes in the fair value of these derivatives are recorded in our condensed consolidated statements of income (loss). These undesignated derivatives are used to hedge monetary net asset and liability positions. Cash flows from our foreign currency derivatives are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

Interest Rate Risk

Interest on our outstanding debt as of August 31, 2026 and February 28, 2026 is based on variable floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on a portion of our outstanding principal balance under the Credit Agreement, which totaled $676.5 million and $785.5 million as of August 31, 2026 and February 28, 2026, respectively. As of August 31, 2026 and February 28, 2026, $300 million and $325 million of the outstanding principal balance under the Credit Agreement, respectively, was hedged with interest rate swaps to fix the interest rate we pay. Our interest rate swaps are designated as cash flow hedges and are recorded on the balance sheet at fair value with changes in fair value recorded in OCI until the hedge transaction is settled, at which point amounts are reclassified from AOCI to our condensed consolidated statements of income (loss). Cash flows from our interest rate swaps are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

The following tables summarize the fair values of our derivative instruments as of the end of the periods presented:
(in thousands)August 31, 2026

Derivatives designated as hedging instruments		Hedge
Type		Final
Settlement Date		Notional AmountPrepaid
Expenses
and Other
Current Assets		Other AssetsAccrued
Expenses
and Other
Current Liabilities		Other
Liabilities, Non- Current
Forward contracts - sell EuroCash flow1/2028€47,600 $969 $200 $59 $— 
Forward contracts - sell Canadian DollarsCash flow10/2027$24,750 177 26 36 — 
Forward contracts - sell PoundsCash flow2/2028£24,500 — 12 861 50 
Forward contracts - sell Norwegian KronerCash flow8/2027kr35,450 18 — 74 — 
Forward contracts - sell Mexican PesosCash flow2/2028$125,000 — — 159 51 
Interest rate swaps Cash flow8/2027$300,000 1,896 — — — 
Subtotal3,060 238 1,189 101 
Derivatives not designated under hedge accounting
Forward contracts - sell Euro
(1)9/2026€3,094 — — 22 — 
Forward contracts - buy Pounds
(1)9/2026£2,643 11 — — — 
Subtotal11 — 22 — 
Total fair value$3,071 $238 $1,211 $101 
17

(in thousands)February 28, 2026

Derivatives designated as hedging instruments		Hedge TypeFinal
Settlement Date		Notional AmountPrepaid
Expenses
and Other
Current Assets		Other AssetsAccrued
Expenses
and Other
Current Liabilities		Other
Liabilities Non- Current
Forward contracts - sell EuroCash flow11/2027€67,000 $149 $137 $1,239 $— 
Forward contracts - sell Canadian DollarsCash flow10/2027$29,600 23 8 330 — 
Forward contracts - sell PoundsCash flow12/2027£32,000 — 33 1,174 42 
Forward contracts - sell Norwegian KronerCash flow2/2027kr30,000 — — 156 — 
Interest rate swaps (2)Cash flow8/2027$425,000 381 — 130 66 
Subtotal553 178 3,029 108 
Derivatives not designated under hedge accounting
Forward contracts - sell Euro
(1)3/2026€6,764 25 — — — 
Forward contracts - buy Pounds(1)3/2026£787 — — 13 — 
Subtotal25 — 13 — 
Total fair value$578 $178 $3,042 $108 
(1)These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements.
(2)Includes a forward-starting interest rate swap agreement with a notional amount of $100 million that became effective on March 1, 2026.

The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented:
Three Months Ended August 31,
Gain (Loss)
Recognized in AOCI
Gain (Loss) Reclassified
from AOCI into Income
(in thousands)20262025Location20262025
Foreign currency contracts - cash flow hedges$594 $(2,368)Sales revenue, net$101 $(1,770)
Interest rate swaps - cash flow hedges582 (743)Interest expense415 1,149 
Total$1,176 $(3,111)$516 $(621)

Six Months Ended August 31,
Gain (Loss)
Recognized in AOCI		Gain (Loss) Reclassified
from AOCI into Income
(in thousands)20262025Location20262025
Foreign currency contracts - cash flow hedges$2,405 $(12,075)Sales revenue, net$(298)$(2,493)
Interest rate swaps - cash flow hedges2,524 1,870 Interest expense813 2,077 
Total$4,929 $(10,205)$515 $(416)

The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented:
Gain (Loss) 
Recognized in Income
Three Months Ended August 31,Six Months Ended August 31,
(in thousands)Location2026202520262025
Forward contractsSG&A$96 $(169)$188 $(505)
Total$96 $(169)$188 $(505)
18

We expect a net gain of $1.9 million associated with foreign currency contracts and interest rate swaps currently recorded in AOCI to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle. See Notes 10 and 12 for more information.

Counterparty Credit Risk

Financial instruments, including foreign currency contracts, forward contracts and interest rate swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. We believe that the risk of incurring credit losses is remote.

Note 12 - Accumulated Other Comprehensive Income (Loss)

The changes in AOCI by component and related tax effects for the periods presented were as follows:
(in thousands)Interest
Rate Swaps		Foreign
Currency
Contracts		Total
Balance at February 28, 2025$646 $1,632 $2,278 
Other comprehensive income (loss) before reclassification1,870 (12,075)(10,205)
Amounts reclassified out of AOCI(2,077)2,493 416 
Tax effects50 2,000 2,050 
Other comprehensive loss(157)(7,582)(7,739)
Balance at August 31, 2025$489 $(5,950)$(5,461)
Balance at February 28, 2026$141 $(2,018)$(1,877)
Other comprehensive income before reclassification2,524 2,405 4,929 
Amounts reclassified out of AOCI(813)298 (515)
Tax effects(397)(431)(828)
Other comprehensive income1,314 2,272 3,586 
Balance at August 31, 2026$1,455 $254 $1,709 
See Notes 10 and 11 for additional information regarding our cash flow hedges.

Note 13 - Segment and Geographic Information

Segment Information

We operate through two strategic business divisions, each comprised of operating segments organized by our brands and product lines. Operating segments with similar economic and qualitative characteristics are aggregated into our two reportable segments, which align with our strategic business divisions. Our two reportable segments consist of Home & Outdoor and Beauty & Wellness. For additional information on our segments refer to Note 1.

Segment financial information is prepared in accordance with GAAP and our significant accounting policies described in Note 1 of our Form 10-K. Resources are allocated and performance is assessed using segment operating income by our Chief Executive Officer, whom we have determined to be our Chief Operating Decision Maker (“CODM”). Our CODM utilizes segment operating income when making decisions about allocating capital and personnel to the segments, predominantly in the annual budget and quarterly forecasting processes. In addition, our CODM uses operating income, including
19

comparison of actual results to budget and forecast, in assessing the performance of each segment and in evaluating product pricing, distribution strategies and marketing investments. Our CODM reviews balance sheet information at a consolidated level. We compute segment operating income based on net sales revenue, less cost of goods sold, SG&A, asset impairment charges and restructuring charges. The SG&A used to compute each segment’s operating income is directly associated with the segment, plus shared services and corporate overhead expenses that are allocable to the segment. We do not allocate non-operating income and expense, including interest or income taxes, to operating segments.

The following tables summarize reportable segment information with a reconciliation to our condensed consolidated results for the periods presented:
Three Months Ended August 31, 2026
(in thousands)Home & OutdoorBeauty & WellnessTotal
Sales revenue, net$227,920 $213,006 $440,926 
Less: (1)
Cost of goods sold (2)101,832 108,971 210,803 
Operating expense (3)102,021 105,183 207,204 
Operating income (loss)$24,067 $(1,148)$22,919 
Non-operating income, net1,761 
Interest expense10,892 
Income before income tax$13,788 
Three Months Ended August 31, 2025
(in thousands)Home & OutdoorBeauty & WellnessTotal
Sales revenue, net$208,721 $223,060 $431,781 
Less: (1)
Cost of goods sold108,636 132,464 241,100 
Operating expense (3)172,663 333,735 506,398 
Operating loss$(72,578)$(243,139)$(315,717)
Non-operating income, net249 
Interest expense14,221 
Loss before income tax$(329,689)
Six Months Ended August 31, 2026
(in thousands)Home & OutdoorBeauty & WellnessTotal
Sales revenue, net$422,843 $420,198 $843,041 
Less: (1)
Cost of goods sold (2)200,337 227,726 428,063 
Operating expense (3)190,274 141,436 331,710 
Operating income$32,232 $51,036 $83,268 
Non-operating income, net1,979 
Interest expense23,135 
Income before income tax$62,112 
20

Six Months Ended August 31, 2025
(in thousands)Home & OutdoorBeauty & WellnessTotal
Sales revenue, net$386,704 $416,732 $803,436 
Less: (1)
Cost of goods sold198,529 239,215 437,744 
Operating expense (3)474,546 613,901 1,088,447 
Operating loss$(286,371)$(436,384)$(722,755)
Non-operating income, net557 
Interest expense28,029 
Loss before income tax$(750,227)
(1)These significant expense categories and amounts align with the reportable segment information that is regularly provided to the CODM.
(2)Cost of goods sold during the three and six months ended August 31, 2026 includes reductions for tariff refunds recognized totaling $26.9 million and $28.7 million, respectively, of which $12.4 million and $14.2 million was recognized in our Home & Outdoor segment, respectively, and $14.5 million was recognized in our Beauty & Wellness segment for both the three and six months ended August 31, 2026. See Note 8 for further information.
(3)Operating expense for both reportable segments includes SG&A expense and restructuring charges. Operating expense during the six months ended August 31, 2026 also includes a gain of $54.9 million on the sale of our distribution facility in Southaven, Mississippi recognized in our Beauty & Wellness segment. Operating expense during the three and six months ended August 31, 2025 also includes asset impairment charges of $326.4 million and $740.8 million, respectively, of which $85.5 million and $304.6 million was recognized in our Home & Outdoor segment, respectively, and $240.9 million and $436.1 million was recognized in our Beauty & Wellness segment, respectively. See Note 3 and Note 5 for further information on the sale of our distribution facility and asset impairment charges, respectively.

The following tables summarize reportable segment information for the periods presented:
Three Months Ended August 31, 2026
(in thousands)Home & OutdoorBeauty & WellnessTotal
Capital and intangible asset expenditures$2,768 $9,537 $12,305 
Depreciation and amortization5,865 7,155 13,020 
Non-cash share-based compensation2,514 2,629 5,143 

Three Months Ended August 31, 2025
(in thousands)Home & OutdoorBeauty & WellnessTotal
Capital and intangible asset expenditures$6,907 $4,563 $11,470 
Depreciation and amortization6,040 6,820 12,860 
Non-cash share-based compensation4,248 5,124 9,372 
Asset impairment charges85,537 240,857 326,394 

Six Months Ended August 31, 2026
(in thousands)Home & OutdoorBeauty & WellnessTotal
Capital and intangible asset expenditures$4,596 $13,515 $18,111 
Depreciation and amortization12,357 14,040 26,397 
Non-cash share-based compensation5,308 6,272 11,580 

Six Months Ended August 31, 2025
(in thousands)Home & OutdoorBeauty & WellnessTotal
Capital and intangible asset expenditures$13,890 $10,942 $24,832 
Depreciation and amortization12,599 14,345 26,944 
Non-cash share-based compensation4,282 5,386 9,668 
Asset impairment charges304,632 436,147 740,779 

21

Geographic Information

The following table presents net sales revenue by geographic region, in U.S. Dollars:
Three Months Ended August 31,Six Months Ended August 31,
(in thousands)2026202520262025
Domestic sales revenue, net (1)
$335,868 76.2 %$330,496 76.5 %$643,216 76.3 %$608,456 75.7 %
International sales revenue, net105,058 23.8 %101,285 23.5 %199,825 23.7 %194,980 24.3 %
Total sales revenue, net$440,926 100.0 %$431,781 100.0 %$843,041 100.0 %$803,436 100.0 %
(1)Domestic net sales revenue includes net sales revenue from the U.S. and Canada.

Note 14 - Income Taxes

We reorganized the Company in Bermuda in 1994, and many of our foreign subsidiaries are not directly or indirectly owned by a U.S. parent. As such, a significant portion of our foreign income is not subject to U.S. taxation on a permanent basis under current law. Additionally, our intangible assets are primarily owned by foreign affiliates, generally resulting in proportionally higher earnings in jurisdictions with statutory tax rates lower than the U.S. Taxable income in each jurisdiction, whether U.S. or foreign, is determined by the subsidiary’s operating results as well as applicable transfer pricing and tax regulations.

For interim periods, our income tax expense and resulting effective tax rate are based on an estimated annual effective tax rate, adjusted for the impact of discrete items recognized in the period. Jurisdictions with year-to-date or forecasted losses for which a tax benefit cannot be recognized are excluded from the estimated annual effective tax rate calculation, which may increase the effective tax rate in interim periods.

Discrete items are recognized in the period in which they occur and include changes in tax laws or rates, changes in estimates for uncertain tax positions, excess tax benefits or deficiencies from stock-based compensation, foreign currency remeasurement effects that cannot be reasonably estimated as part of the annual effective tax rate, and other infrequent or non-recurring items. Discrete items do not include the asset impairment charges described below and in Note 5.

During the three and six months ended August 31, 2025, we recognized goodwill and other intangible asset impairment charges of $326.4 million and $740.8 million, respectively, which included $246.0 million and $511.0 million, respectively, of non-deductible goodwill that did not result in a tax benefit. The tax benefit on the impairment charge was recognized over the course of fiscal 2026 in relation to pre-tax book income, rather than as a discrete item in the periods in which the charges were incurred.

The downward revisions to our internal forecasts utilized in our impairment testing during the first half of fiscal 2026 impacted our assessment of the future realizability of a related deferred tax asset, which led to the recording of discrete valuation allowances of $13.5 million and $30.0 million during the three and six months ended August 31, 2025, respectively.

For the three months ended August 31, 2026, income tax expense was $9.2 million on pre-tax income of $13.8 million, compared to an income tax benefit of $21.0 million on a pre-tax loss of $329.7 million for the same period last year. The increase in income tax expense and effective tax rate was primarily due to an increase in jurisdictions with losses excluded from the estimated annual effective tax rate calculation in fiscal 2027, and was also affected by impairment charges and the timing of related tax effects and deferred tax asset valuation allowances recognized in the same period last year.

22

For the six months ended August 31, 2026, income tax expense was $21.7 million on pre-tax income of $62.1 million, compared to income tax expense of $9.1 million on a pre-tax loss of $750.2 million for the same period last year. The increase in income tax expense and effective tax rate was primarily due to income tax expense recognized on the gain from the sale of our distribution facility in Southaven, Mississippi and an increase in jurisdictions with losses excluded from the estimated annual effective tax rate calculation in fiscal 2027, and was also affected by impairment charges and the timing of related tax effects and deferred tax asset valuation allowances recognized in the same period last year.

Note 15 - Earnings Per Share

We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time consist of issued and contingently issuable unvested restricted stock units, performance stock units, restricted stock awards and performance restricted stock awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. See Note 6 to these condensed consolidated financial statements for more information regarding stock-based awards.

The following table presents our weighted average basic and diluted shares outstanding for the periods shown:
Three Months Ended August 31,Six Months Ended August 31,
(in thousands)2026202520262025
Weighted average shares outstanding, basic23,295 22,959 23,280 22,951 
Incremental shares from share-based compensation arrangements858 — 676 — 
Weighted average shares outstanding, diluted (1)
24,153 22,959 23,956 22,951 
Anti-dilutive securities46 454 140 442 
(1)Due to the net loss for the three and six months ended August 31, 2025, 53 thousand and 41 thousand incremental shares, respectively, from share-based compensation arrangements were excluded from the computation of diluted weighted average shares outstanding because their effect would be anti-dilutive.

23

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with our condensed consolidated financial statements included under Item 1., “Financial Statements.” The various sections of this MD&A contain a number of forward-looking statements, all of which are based on our current expectations. Actual results may differ materially due to a number of factors, including those discussed in the section entitled “Information Regarding Forward-Looking Statements” following this MD&A, and in Item 3., “Quantitative and Qualitative Disclosures About Market Risk” in this report, as well as in Part I, Item IA., “Risk Factors” in the Company’s most recent annual report on Form 10-K for the fiscal year ended February 28, 2026 (“Form 10-K”) and its other filings with the Securities and Exchange Commission (the “SEC”). When used in this MD&A, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us” or “our” refer to Helen of Troy Limited and its subsidiaries. References to “fiscal” in connection with a numeric year number denotes our fiscal year ending on the last day of February, during the year number listed.

This MD&A, including the tables under the headings “Operating Income (Loss), Operating Margin, Adjusted Operating Income (non-GAAP) and Adjusted Operating Margin (non-GAAP) by Segment” and “Net Income (Loss), Diluted Earnings (Loss) Per Share, Adjusted Income (non-GAAP) and Adjusted Diluted Earnings Per Share (non-GAAP),” reports operating income (loss), operating margin, net income (loss) and diluted earnings (loss) per share without the impact of asset impairment charges, costs incurred in connection with the departure of our former Chief Executive Officer (“CEO”) primarily related to severance and recruitment costs (“CEO succession costs”), settlement costs and legal fees related to lawsuits involving products sold by the North America personal care business divested on June 7, 2021, for which we tendered indemnification and are discussed further below (referred to as “divestiture litigation costs”), gain on the sale of our distribution facility in Southaven, Mississippi during the first quarter of fiscal 2027 (“gain on sale of distribution facility”), income tax expense from the recognition of valuation allowances in fiscal 2026 on deferred tax assets related to our intangible asset reorganization in fiscal 2025 (“intangible asset reorganization”), restructuring charges, amortization of intangible assets, and non-cash share-based compensation for the periods presented, as applicable. These measures may be considered non-GAAP financial measures as defined by SEC Regulation G, Rule 100. The tables reconcile these measures to their corresponding GAAP-based financial measures presented in our condensed consolidated statements of income (loss). We believe that adjusted operating income, adjusted operating margin, adjusted income and adjusted diluted earnings per share provide useful information to management and investors regarding financial and business trends relating to our financial condition and results of operations. We believe that these non-GAAP financial measures, in combination with our financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of such charges and benefits on applicable income, margin and earnings per share measures. We also believe that these non-GAAP measures reflect the operating performance of our business and facilitate a more direct comparison of our performance to our competitors. The material limitation associated with the use of the non-GAAP financial measures is that the non-GAAP measures do not reflect the full economic impact of our activities. Our adjusted operating income, adjusted operating margin, adjusted income and adjusted diluted earnings per share are not prepared in accordance with GAAP, are not an alternative to GAAP financial measures and may be calculated differently than non-GAAP financial measures disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP financial measures. These non-GAAP financial measures are discussed further and reconciled to their applicable GAAP-based financial measures contained in this MD&A beginning on page 38.

There were no material changes to the key financial measures discussed in our Form 10-K.

24

Overview

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. Our portfolio of brands includes OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive & June, among others. We have built leading market positions through new product innovation, product quality and competitive pricing. As of August 31, 2026, we operated two reportable segments: Home & Outdoor and Beauty & Wellness.

On April 14, 2026, we completed the sale of our distribution facility in Southaven, Mississippi for a total sales price of $82.0 million, less costs to sell of $3.8 million. Accordingly, we recognized a gain on the sale of $54.9 million within “Selling, general and administrative expense” (“SG&A”) during the first quarter of fiscal 2027, which was recognized by our Beauty & Wellness segment. We used the proceeds from the sale to repay amounts outstanding under our credit facility.

We did not record any asset impairment charges during the first six months of fiscal 2027. During the first and second quarters of fiscal 2026, we concluded a goodwill impairment triggering event had occurred due to a sustained decline in our stock price, and performed quantitative impairment testing on our goodwill and certain intangible assets. As a result of such testing, we recorded pre-tax asset impairment charges as follows:
(in thousands)Three Months Ended August 31, 2025Six Months Ended August 31, 2025
Home & Outdoor (1)
$85,537 $304,632 
Beauty & Wellness (2)
240,857 436,147 
Total
$326,394 $740,779 
(1)Asset impairment charges recognized for our Home & Outdoor segment included charges for our Hydro Flask and Osprey businesses of $44.7 million and $40.8 million, respectively, for the three months ended August 31, 2025 and $165.5 million and $139.1 million, respectively, for the six months ended August 31, 2025.
(2)Asset impairment charges recognized for our Beauty & Wellness segment included charges for our Health & Wellness, Drybar, Curlsmith and Revlon businesses of $160.9 million, $47.8 million, $28.4 million and $3.9 million, respectively, for the three months ended August 31, 2025 and $196.6 million, $151.4 million, $64.6 million and $23.5 million, respectively, for the six months ended August 31, 2025.

For additional information regarding the testing and analysis performed, see Note 5 to the accompanying condensed consolidated financial statements.

Significant Trends Impacting the Business

Impact of Tariffs
Since 2019, the Office of the United States Trade Representative (“USTR”) has imposed, and in certain cases subsequently reduced or suspended, additional tariffs on products imported from China and other foreign countries. Additionally, the current United States (“U.S.”) presidential administration has promoted and implemented plans to raise tariffs even further and pursue other trade policies intended to restrict imports. Our purchases of products from unaffiliated manufacturers located in China and other regions exposes us to higher costs of doing business from increases in tariffs.

Under the International Emergency Economic Powers Act (“IEEPA”), the U.S. presidential administration began implementing fentanyl-related IEEPA tariffs (“Fentanyl IEEPA Tariff”) and additional tariffs (“Reciprocal IEEPA Tariff”) during calendar year 2025. As of April 9, 2025, the U.S. had imposed (i) an aggregate additional 145% tariff on imports from China, consisting of a 20% Fentanyl IEEPA Tariff and 125% Reciprocal IEEPA Tariff and (ii) a global 10% Reciprocal IEEPA Tariff on imports from other
25

countries including Mexico, Vietnam and other U.S. trading partners. The Reciprocal IEEPA Tariff on imports from China was subsequently lowered to 10% effective May 12, 2025, resulting in an aggregate additional 30% tariff. On July 31, 2025, the U.S. president signed an executive order imposing new IEEPA tariffs on a number of U.S. trading partners which became effective on August 7, 2025, including a 25% Fentanyl IEEPA Tariff on imports from Mexico and a 20% and 19% Reciprocal IEEPA Tariff on imports from Vietnam and Thailand, respectively. Effective November 10, 2025, the 10% Reciprocal IEEPA Tariff on imports from China, which was set to expire, was extended to remain in effect through November 10, 2026, and the Fentanyl IEEPA Tariff was reduced from 20% to 10%, reducing the aggregate additional tariff from 30% to 20%. On February 20, 2026, the U.S. Supreme Court ruled that tariffs imposed by the U.S. president under IEEPA were unconstitutional, and the U.S. president subsequently imposed a temporary global 10% Section 122 tariff under the Trade Act of 1974 (“Section 122 Tariff”) effective February 24, 2026 through July 24, 2026. As a result, the previous aggregate additional tariff on imports from China, Vietnam, Mexico and Thailand of 20%, 20%, 25% and 19%, respectively, were replaced by the 10% Section 122 Tariff. In May 2026, the U.S. Court of International Trade (“CIT”) found the Section 122 Tariff unlawful in certain cases; however, the Section 122 Tariff remained in place through its expiration on July 24, 2026 for the Company and most importers while the cases proceeded through the appeals process. Our imports manufactured in Mexico were not impacted by the IEEPA tariffs or Section 122 Tariff since they qualified for duty-free preference under the United States-Mexico-Canada Agreement (the “USMCA”).

Following the expiration of the Section 122 Tariff discussed above, effective July 24, 2026, the U.S. presidential administration imposed tariffs under Section 301 of the Trade Act of 1974 (“Section 301 Tariff”) on 60 countries, including 10% for Mexico and 12.5% for China, Vietnam and Thailand, for failure to impose and effectively enforce a prohibition on the importation of goods produced with forced labor. The Section 301 Tariff for Mexico is unchanged from the prior Section 122 Tariff and represents an increase of 2.5% on imports from China, Vietnam and Thailand. As a result, our products imported from China, Vietnam, Thailand and other countries are currently subject to the Section 301 Tariff. Our imports manufactured in Mexico are not impacted by the Section 301 Tariff since they qualify for duty-free preference under the USMCA. Further, we benefit from certain exclusions from tariffs as a result of the COVID-19 pandemic, which were extended to November 9, 2026. The U.S. presidential administration is considering additional Section 301 Tariffs as a remedy for unfair trade practices; however, the review process is ongoing.

In response to recent tariffs imposed by the U.S. on certain Canadian goods under Section 338 of the Tariff Act of 1930, Canada imposed retaliatory tariffs ranging from 15% to 50% on similar American goods effective September 8, 2026. Currently, our liquid hair styling products, treatments and conditioners within our Beauty & Wellness business are subject to this 50% tariff upon importation to Canada and do not qualify for duty-free preference under the USMCA.

In March 2025, the U.S. president also implemented changes under Section 232 of the Trade Expansion Act of 1962 (“Section 232 Tariffs”) which resulted in additional sectoral tariffs to aluminum and steel of 25%. On June 4, 2025, the Section 232 Tariffs related to aluminum and steel were increased to 50%, and effective August 1, 2025, expanded to include copper products and components. Section 232 Tariffs were previously imposed based solely on a metal content-based calculation. Effective April 6, 2026, Section 232 Tariffs were expanded to apply to the entire customs value of covered products with tiered rates based on metal content and origin. Currently, our products are not subject to the Section 232 Tariffs on copper products and components. Our products are currently subject to the Section 232 Tariffs on aluminum and steel products of 25%, which primarily impacts certain products within our Home and Wellness businesses.

On March 4, 2026, the CIT issued an additional ruling that importers that paid tariffs under IEEPA are due refunds and ordered U.S. Customs and Border Protection (“CBP”) to begin the refund process for all
26

importers who were subject to IEEPA duties. During fiscal 2026 and 2027, we paid IEEPA tariffs totaling $80.5 million. On April 20, 2026, CBP launched Phase 1 of a process for submitting IEEPA refund claims, and on June 29, 2026, CBP launched Phase 2 of the IEEPA refund claims process. CBP has established the framework for Phase 3 of the IEEPA refund claims process, and the Company was notified in August 2026 of its eligibility to participate. The Company plans to start filing Phase 3 refund claims after CBP begins accepting submissions. As of August 31, 2026, we collected all our Phase 1 tariff refunds and concluded that our submitted Phase 2 tariff refund claims were probable of being recovered, substantially all of which were approved by CBP prior to August 31, 2026. As a result, during the three and six months ended August 31, 2026, we recognized reductions to “Cost of goods sold” of $26.9 million and $28.7 million, respectively. As of August 31, 2026, our receivable for tariff refunds included within prepaids and other current assets totaled $4.3 million and our reduction to inventory for tariff refunds totaled $0.8 million. During the six months ended August 31, 2026, we collected $25.3 million in tariff refunds. The Company will continue to monitor regulatory guidance regarding the refund process, file additional Phase 2 and 3 claims and recognize additional recoveries when the right to receipt becomes probable.

During fiscal 2026 and the first quarter of fiscal 2027, tariffs had a net adverse impact on our cost of goods sold. During the three and six months ended August 31, 2026, tariffs had a net favorable impact on our cost of goods sold as a result of recognizing tariff refunds of $26.9 million and $28.7 million, respectively, as discussed above. Our cost of goods sold included additional pre-tax tariff costs related to the changes in tariffs described above of $12.6 million and $27.3 million, during the three and six months ended August 31, 2026, respectively, compared to $10.0 million and $12.5 million in the same periods last year, respectively. While we successfully implemented strategic price increases during fiscal 2026 to help mitigate the impact of tariffs, we believe the benefit to net sales revenue in fiscal 2027 is entirely offset by reduced unit sales volumes due to consumer price elasticity. Our net sales revenue during the first six months of fiscal 2026 was negatively impacted by a combination of factors including the pause or cancellation of direct import orders from China by certain of our key retailers in response to increased tariff rates, a slowdown in retailer orders following pull forward activity in the fourth quarter of fiscal 2025 due to tariff uncertainty and lower consumer confidence and demand. In addition, net sales revenue during the first six months of fiscal 2026 was negatively impacted by evolving dynamics in the China market, including a shift toward localized fulfillment models and heightened competition from domestic sellers benefiting from government subsidies. In addition to the uncertainty from evolving global tariff policies, we experienced and expect continued unfavorable cascading impacts on inflation, consumer confidence, employment and overall macroeconomic conditions, all of which may continue to adversely impact our sales, results of operations and cash flows.

U.S. tariff policies continue to evolve, as well as the corresponding impacts on global trade policies. As a result, our risks and mitigation plans, as further described below, will also continue to evolve as further developments arise. Any further alteration of trade agreements and terms between China, Vietnam, Mexico and the U.S., including limiting trade with China, Vietnam and Mexico, imposing additional tariffs on imports from China, Vietnam or Mexico and potentially imposing other restrictions on imports from China, Vietnam or Mexico, to the U.S., may result in further or higher tariffs or retaliatory trade measures by China, Vietnam or Mexico, all of which could have a material adverse effect on our business and operating results.

We continue to assess our incremental tariff cost exposure in light of continuing changes to global tariff policies and the full extent of our potential mitigation plans, as well as the associated timing to implement such plans and realize the anticipated benefits. To mitigate our risk of ongoing exposure to tariffs, we continue to pursue opportunities to diversify our production capabilities outside of China into regions where we expect tariffs or overall costs to be lower and to source the same product in more than one region, to the extent it is possible and not cost-prohibitive.

27

Impact of Macroeconomic Trends
The Federal Open Market Committee lowered the benchmark interest rate by 50 basis points and 25 basis points during the third and fourth quarters of fiscal 2026, respectively, resulting in lower average interest rates incurred during the first six months of fiscal 2027 compared to the same period last year. The Federal Open Market Committee raised the benchmark interest rate by 25 basis points subsequent to the second quarter of fiscal 2027. As of August 31, 2026 and February 28, 2026, $300 million and $325 million of the outstanding principal balance under the Credit Agreement (as defined below), respectively, was hedged with interest rate swaps to fix the interest rate we pay. The weighted average interest rates on borrowings outstanding under the Credit Agreement inclusive of the impact of our interest rate swaps as of August 31, 2026 and February 28, 2026 were 5.5% and 5.7%, respectively. The weighted average interest rate on borrowings hedged with interest rate swaps was 3.3% as of both August 31, 2026 and February 28, 2026. The comparable Term SOFR interest rate (as defined in the Credit Agreement) was 3.7% as of both August 31, 2026 and February 28, 2026. While the actual timing and extent of additional future changes in interest rates remains unknown, higher average interest rates would increase interest expense on our outstanding variable rate debt not subject to the interest rate swaps. The financial markets, the global economy and global supply chain may also be adversely affected by the current or anticipated impact of military conflicts or other geopolitical events, as well as recent U.S. tariff policies, that are continuing to evolve and the corresponding impacts on global trade. Most recently, the outcome of the ongoing Israel-United States and Iran conflict is highly unpredictable and could lead to significant market and other disruptions, including significant volatility in the commodity prices and supply of energy resources and supply chain interruptions. High inflation has also negatively impacted consumer disposable income, credit availability and spending, among others, which have adversely impacted our business, financial condition, cash flows and results of operations during fiscal 2026 and the first six months of fiscal 2027 and may continue to have an adverse impact during the remainder of fiscal 2027. Evolving global tariff policies, military conflicts or geopolitical events (such as the Israel-United States and Iran conflict) could adversely impact inflation and interest rates which could further negatively impact consumer disposable income, credit availability and spending. See further discussion below under “Consumer Spending and Changes in Shopping Preferences.” We expect continued uncertainty in our business and the global economy due to pressure from inflation, tariffs, consumer confidence and the Israel-United States and Iran conflict, any of which may adversely impact our results.

Consumer Spending and Changes in Shopping Preferences
Our business depends upon discretionary consumer demand for most of our products and primarily operates within mature and highly developed consumer markets. The principal driver of our operating performance is the strength of the U.S. retail economy. Approximately 72% of our consolidated net sales revenue was from U.S. shipments during both the three months ended August 31, 2026 and 2025. For the six months ended August 31, 2026 and 2025, U.S. shipments were approximately 72% and 71% of our consolidated net sales revenue, respectively.

Among other things, high levels of inflation, interest rates, military conflicts or other geopolitical events, and tariffs may negatively impact consumer disposable income, credit availability and spending. Consumer purchases of discretionary items, including some of the products that we offer, generally decline during recessionary periods or periods of economic uncertainty, when disposable income is reduced or when there is a reduction in consumer confidence. Dynamic changes in consumer spending and shopping patterns are also having an impact on retailer inventory levels. Our ability to sell to retailers is predicated on their ability to sell to the end consumer. During fiscal 2026 and the first half of fiscal 2027, we experienced continued competition within our Beauty & Wellness segment and in the insulated beverageware category. In addition, during fiscal 2026, we experienced lower replenishment orders in line with softer consumer demand and discretionary spending and continued competition, which adversely impacted our sales, results of operations and cash flows. During the first half of fiscal 2027, this trend continued in our Beauty business. If orders from our retail customers continue to be adversely
28

impacted, our sales, results of operations and cash flows may continue to be adversely impacted. We expect continued uncertainty in our business and the global economy due to inflation, evolving global tariff policies, continued competition and changes in consumer spending patterns. Accordingly, our liquidity and financial results could be impacted in ways that we are not able to predict today.

Our concentration of sales reflects the continued evolution of consumer shopping preferences. Our net sales to pure-play online retailers and retail customers fulfilling end-consumer online orders, as well as our own online sales directly to consumers (collectively “online channel net sales”) comprised approximately 25% and 26% of our total consolidated net sales revenue for the three and six months ended August 31, 2026, respectively, and grew approximately 4% and 16% compared to the same periods last year, respectively. For both the three and six months ended August 31, 2025, our online channel net sales comprised approximately 24% of our total consolidated net sales revenue and declined approximately 22% and 20% compared to the same periods last year, respectively.

Packaging Disposal Costs
An emerging trend with governmental and non-governmental organizations, consumers, shareholders, retail customers, communities, and other stakeholders is increased focus and expectations on sustainability matters. These trends have led to, among other things, increased public and private social accountability reporting requirements relating to labor practices, climate change, human trafficking and other sustainability matters and greater demands on our packaging and products. Several U.S. states, Canada, the European Union (“EU”) and Europe, the Middle East and Africa (“EMEA”) have enacted legislation to reduce single use plastics and establish regulatory requirements including extended producer responsibility (“EPR”) programs, which are designed to transfer the cost of packaging disposal from municipalities to producers of consumer-packaged goods. EPR programs typically include reporting requirements for, among other things, post-consumer recycling usage, compostable packaging, material reduction including plastic component data and refill strategies. We are currently subject to EPR programs enacted in the U.S., Canada, EU and EMEA, which require us to partially fund the disposal of our products’ packaging (“packaging disposal costs”). As a result of these EPR programs as well as other regulatory packaging requirements, we are beginning to incur higher packaging related costs. Several states in the U.S. have proposed EPR legislation and jurisdictions such as the EU and Canada are expanding existing program requirements which will increase our operating costs and could adversely impact our business, cash flows and results of operations. In addition, we also intend to invest in the recyclability of our products’ packaging and reduce packaging waste which may further increase our costs initially and could require capital investments. As regulatory requirements continue to evolve, compliance could increase our operating costs, limit material availability, reduce consumer demand for our products in the future, or adversely impact our business, cash flows and results of operations.

EPA Compliance Costs
During fiscal 2022 and 2023, we were in discussions with the U.S. Environmental Protection Agency (“the EPA”) regarding the compliance of packaging and labeling claims on certain of our products in the air and water filtration and humidification categories within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging and labeling compliance discussions, we completed the repackaging and relabeling of impacted products during fiscal 2023. On August 25, 2026, we entered into a final administrative settlement with the EPA related to this matter for $4.4 million, which will be paid in the third quarter of fiscal 2027. As a result, the estimated liability we recognized during fiscal 2026 of $4.4 million remained outstanding as of August 31, 2026. See Note 8 to the accompanying condensed consolidated financial statements for additional information.


29

Talcum Powder Litigation Related to the Fiscal 2022 Personal Care Divestiture
On June 7, 2021, we completed the sale of our North America personal care business to HRB Brands LLC (“HRB Brands”). After the sale, we were named as a defendant in multiple lawsuits related to the use of personal care products previously containing talcum powder, primarily Brut deodorant and Ammens powder sold by our wholly-owned subsidiary, Idelle Labs, Ltd. We tendered indemnification of these cases to HRB Brands, which assumed control of the defense of the claims. After many years, during the fourth quarter of fiscal 2026, HRB Brands asserted that it was contesting the indemnification of these cases and tendered the indemnification back to us. Consequently, in order to protect the Company and its rights and defenses, we began to defend these cases. The Company maintains its position that HRB Brands is obligated to defend and indemnify the Company against these claims and plans to vigorously contest HRB Brands’ position. With respect to the talcum powder cases, we believe we have substantial defenses to the claims. The ultimate outcome of enforcing our indemnification claims against HRB Brands and the litigation relating to the talcum cases is inherently uncertain, and we cannot predict its resolution. During the three and six months ended August 31, 2026, we accrued $4.0 million and $5.3 million, respectively, for potential settlements and legal fees and paid approximately $1.4 million during fiscal 2027 related to these cases. As of August 31, 2026, we had an estimated liability of approximately $5.4 million.

Due to HRB Brands’ failure to continue to indemnify these claims, the resulting incurrence of litigation costs related to a divestiture that occurred over five years ago, and the uncertainty of the timing in enforcing our indemnification claims against HRB Brands, management does not believe such costs are normal operating expenses related to the Company’s ongoing operations, revenue generating activities or business strategy. As a result, beginning with the second quarter of fiscal 2027, management determined that costs related to this matter will be adjusted in our non-GAAP financial measures going forward. Accordingly, our adjusted operating income and adjusted income results that follow exclude $4.0 million of divestiture litigation costs for the three and six months ended August 31, 2026 and are reconciled to their applicable GAAP-based financial measure below. For additional information regarding management’s decision to present non-GAAP financial information, see the introduction to this Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

We cannot estimate the amount or range of amounts by which the liability may exceed the accrual established because of (i) the inherent difficulty in projecting the number of claims that have not yet been asserted or the time period in which future claims may be asserted, (ii) the complaints nearly always assert claims against multiple defendants where the damages alleged are typically not attributed to individual defendants so that a defendant’s share of liability may turn on the law of joint and several liability, which can vary by state, and (iii) the many factors, developments and inherent uncertainties involved with litigation that could affect the Company’s estimate of the liability. For additional information, see Note 8 to the accompanying condensed consolidated financial statements.

Securities Class Action Lawsuit
On June 2, 2026, the Company and certain of its officers were named as defendants in a purported federal securities class action lawsuit filed in the United States District Court for the Western District of Texas. The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b‑5 relating to certain prior disclosures of the Company. The plaintiff seeks to represent a class of shareholders who purchased or otherwise acquired the Company’s common stock between April 24, 2024 and October 8, 2025. The Company believes the allegations asserted in the complaint are without merit and intends to defend them vigorously. At this early stage of the proceedings, the Company is unable to predict the outcome of this matter or reasonably estimate the possible loss or range of loss, if any.


30

Foreign Currency Exchange Rate Fluctuations
Due to the nature of our operations, we have exposure to the impact of fluctuations in exchange rates from transactions that are denominated in a currency other than our functional currency (the U.S. Dollar). Such transactions include sales and operating expenses. The most significant currencies affecting our operating results are the Euro, British Pound and Canadian Dollar.

For the three months ended August 31, 2026, changes in foreign currency exchange rates had a favorable year-over-year impact on consolidated U.S. Dollar reported net sales revenue of approximately $0.1 million, or less than 0.1%, compared to a favorable year-over-year impact of $0.2 million, or less than 0.1%, for the same period last year. For the six months ended August 31, 2026, changes in foreign currency exchange rates had a favorable year-over-year impact on consolidated U.S. Dollar reported net sales revenue of approximately $3.0 million, or 0.4%, compared to an unfavorable year-over-year impact of $0.8 million, or 0.1%, for the same period last year.

Variability of the Cough/Cold/Flu Season
Sales in several of our Beauty & Wellness categories are highly correlated to the severity of winter weather and cough/cold/flu incidence. In the U.S., the cough/cold/flu season historically runs from November through March, with peak activity normally in January to March. The 2025-2026 and 2024-2025 cough/cold/flu seasons were below historical averages seen prior to the impact of COVID-19.
31

RESULTS OF OPERATIONS

The following tables provide selected operating data, in U.S. Dollars, as a percentage of net sales revenue, and as a year-over-year percentage change.
Three Months Ended
August 31, 2026		% of Sales Revenue, net
(in thousands)
2026
2025$ Change% Change20262025
Sales revenue by segment, net
Home & Outdoor$227,920 $208,721 $19,199 9.2 %51.7 %48.3 %
Beauty & Wellness213,006 223,060 (10,054)(4.5)%48.3 %51.7 %
Total sales revenue, net440,926 431,781 9,145 2.1 %100.0 %100.0 %
Cost of goods sold210,803 241,100 (30,297)(12.6)%47.8 %55.8 %
Gross profit230,123 190,681 39,442 20.7 %52.2 %44.2 %
SG&A
204,661 176,999 27,662 15.6 %46.4 %41.0 %
Asset impairment charges— 326,394 (326,394)*— %75.6 %
Restructuring charges2,543 3,005 (462)(15.4)%0.6 %0.7 %
Operating income (loss)22,919 (315,717)338,636 *5.2 %(73.1)%
Non-operating income, net1,761 249 1,512 *0.4 %0.1 %
Interest expense10,892 14,221 (3,329)(23.4)%2.5 %3.3 %
Income (loss) before income tax13,788 (329,689)343,477 *3.1 %(76.4)%
Income tax expense (benefit)9,156 (21,046)30,202 *2.1 %(4.9)%
Net income (loss)$4,632 $(308,643)$313,275 *1.1 %(71.5)%
Six Months Ended
August 31,		% of Sales Revenue, net
(in thousands)
2026
2025
$ Change% Change20262025
Sales revenue by segment, net
Home & Outdoor$422,843 $386,704 $36,139 9.3 %50.2 %48.1 %
Beauty & Wellness420,198 416,732 3,466 0.8 %49.8 %51.9 %
Total sales revenue, net843,041 803,436 39,605 4.9 %100.0 %100.0 %
Cost of goods sold428,063 437,744 (9,681)(2.2)%50.8 %54.5 %
Gross profit414,978 365,692 49,286 13.5 %49.2 %45.5 %
SG&A
329,167 344,663 (15,496)(4.5)%39.0 %42.9 %
Asset impairment charges— 740,779 (740,779)*— %92.2 %
Restructuring charges2,543 3,005 (462)(15.4)%0.3 %0.4 %
Operating income (loss)83,268 (722,755)806,023 *9.9 %(90.0)%
Non-operating income, net1,979 557 1,422 *0.2 %0.1 %
Interest expense23,135 28,029 (4,894)(17.5)%2.7 %3.5 %
Income (loss) before income tax62,112 (750,227)812,339 *7.4 %(93.4)%
Income tax expense21,718 9,134 12,584 *2.6 %1.1 %
Net income (loss)$40,394 $(759,361)$799,755 *4.8 %(94.5)%

* Calculation is not meaningful.

32

Second Quarter Fiscal 2027 Financial Results

•Consolidated net sales revenue increased $9.1 million, or 2.1%, to $440.9 million for the three months ended August 31, 2026, compared to $431.8 million for the same period last year.

•Consolidated operating income was $22.9 million for the three months ended August 31, 2026, compared to consolidated operating loss of $315.7 million for the same period last year. Consolidated operating loss for the three months ended August 31, 2025 included pre-tax asset impairment charges of $326.4 million. Consolidated operating margin increased to 5.2% of consolidated net sales revenue for the three months ended August 31, 2026, compared to (73.1)% for the same period last year.

•Consolidated adjusted operating income increased $11.0 million, or 40.9%, to $37.9 million for the three months ended August 31, 2026, compared to $26.9 million for the same period last year. Consolidated adjusted operating margin increased 2.4 percentage points to 8.6% of consolidated net sales revenue for the three months ended August 31, 2026, compared to 6.2% for the same period last year.

•Net income was $4.6 million for the three months ended August 31, 2026, compared to net loss of $308.6 million for the same period last year. Diluted earnings per share was $0.19 for the three months ended August 31, 2026, compared to diluted loss per share of $13.44 for the same period last year.

•Adjusted income increased $5.5 million, or 40.3%, to $19.0 million for the three months ended August 31, 2026, compared to $13.5 million for the same period last year. Adjusted diluted earnings per share increased 33.9% to $0.79 for the three months ended August 31, 2026, compared to $0.59 for the same period last year.

Year-To-Date Fiscal 2027 Financial Results

•Consolidated net sales revenue increased $39.6 million, or 4.9%, to $843.0 million for the six months ended August 31, 2026, compared to $803.4 million for the same period last year.

•Consolidated operating income was $83.3 million for the six months ended August 31, 2026, compared to consolidated operating loss of $722.8 million for the same period last year. Consolidated operating loss for the six months ended August 31, 2025 included pre-tax asset impairment charges of $740.8 million. Consolidated operating margin increased to 9.9% of consolidated net sales revenue for the six months ended August 31, 2026, compared to (90.0)% for the same period last year.

•Consolidated adjusted operating income increased $11.0 million, or 25.5%, to $54.0 million for the six months ended August 31, 2026, compared to $43.1 million for the same period last year. Consolidated adjusted operating margin increased 1.0 percentage points to 6.4% of consolidated net sales revenue for the six months ended August 31, 2026, compared to 5.4% for the same period last year.

•Net income was $40.4 million for the six months ended August 31, 2026, compared to net loss of $759.4 million for the same period last year. Diluted earnings per share was $1.69 for the six months ended August 31, 2026, compared to diluted loss per share of $33.09 for the same period last year.

33

•Adjusted income was $23.0 million for both the six months ended August 31, 2026 and 2025. Adjusted diluted earnings per share decreased 4.0% to $0.96 for the six months ended August 31, 2026, compared to $1.00 for the same period last year.

Consolidated and Segment Net Sales Revenue

The following tables summarize the impact that Organic business and foreign currency had on our net sales revenue by segment: 
Three Months Ended August 31,
(in thousands)Home & OutdoorBeauty & WellnessTotal
Fiscal 2026 sales revenue, net
$208,721 $223,060 $431,781 
Organic business19,420 (10,359)9,061 
Impact of foreign currency(221)305 84 
Change in sales revenue, net19,199 (10,054)9,145 
Fiscal 2027 sales revenue, net
$227,920 $213,006 $440,926 
Total net sales revenue growth (decline)9.2 %(4.5)%2.1 %
Organic business9.3 %(4.6)%2.1 %
Impact of foreign currency(0.1)%0.1 %— %

Six Months Ended August 31,
(in thousands)Home & OutdoorBeauty & WellnessTotal
Fiscal 2026 sales revenue, net
$386,704 $416,732 $803,436 
Organic business35,043 1,604 36,647 
Impact of foreign currency1,096 1,862 2,958 
Change in sales revenue, net36,139 3,466 39,605 
Fiscal 2027 sales revenue, net
$422,843 $420,198 $843,041 
Total net sales revenue growth (decline)
9.3 %0.8 %4.9 %
Organic business9.1 %0.4 %4.6 %
Impact of foreign currency0.3 %0.4 %0.4 %

In the above tables, Organic business refers to our net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand was acquired, excluding the impact that foreign currency remeasurement had on reported net sales revenue. Net sales revenue from internally developed brands or product lines is considered Organic business activity.

Consolidated Net Sales Revenue

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Consolidated net sales revenue increased $9.1 million, or 2.1%, to $440.9 million, compared to $431.8 million. The increase was primarily driven by an increase in Home & Outdoor reflecting growth across all brands due to strong demand for packs, higher international sales, assortment and distribution gains, higher closeout channel sales, and new product launches. This increase was partially offset by a decrease in Beauty & Wellness driven by declines in hair appliances, prestige hair care and water filtration, which was partially offset by growth in heaters, thermometers and nail care.

Consolidated net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $0.1 million, or less than 0.1%.
34

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Consolidated net sales revenue increased $39.6 million, or 4.9%, to $843.0 million, compared to $803.4 million. The increase was primarily driven by:
•an increase in Home & Outdoor reflecting growth across all brands due to strong demand for packs, new product launches, higher closeout channel sales, and the favorable comparative impact of retailer pull-forward activity in the fourth quarter of fiscal 2025 in response to tariff uncertainty; and
•an increase in Beauty & Wellness due to growth in fans, thermometers, heaters and nail care, which was partially offset by a decline in hair appliances and prestige hair care products.

Consolidated net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $3.0 million, or 0.4%.

Segment Net Sales Revenue 

Home & Outdoor

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Net sales revenue increased $19.2 million, or 9.2%, to $227.9 million, compared to $208.7 million. The increase reflects growth across all brands and was primarily driven by:
•strong demand for technical, travel and lifestyle packs;
•an increase in international sales;
•assortment and distributions gains;
•higher closeout channel sales; and
•incremental sales from new product launches.

Segment net sales revenue was unfavorably impacted by net foreign currency fluctuations of approximately $0.2 million, or 0.1%.

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Net sales revenue increased $36.1 million, or 9.3%, to $422.8 million, compared to $386.7 million. The increase reflects growth across all brands and was primarily driven by:
•strong demand for technical, lifestyle and travel packs across all channels;
•the favorable comparative impact of lower first quarter fiscal 2026 sales due to retailer pull-forward activity in the fourth quarter of fiscal 2025 in response to tariff uncertainty and potential supply disruption;
•incremental sales from new product launches;
•higher closeout channel sales; and
•increased sales from new and expanded distribution in the home category.

These factors were partially offset by a decrease in international and club channel sales in the home category.

Segment net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $1.1 million, or 0.3%.


35

Beauty & Wellness

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Net sales revenue decreased $10.1 million, or 4.5%, to $213.0 million, compared to $223.1 million. The decrease was primarily driven by:
•a decline in Beauty hair appliances and prestige hair care products primarily due to softer consumer demand, including the impact of consumer price sensitivity, continued competition, reduced replenishment orders from retail customers and lower closeout channel sales; and
•a decrease in water filtration primarily driven by softer consumer demand and increased competitive marketing activity.

These factors were partially offset by:
•an increase in heater and thermometer sales benefitting from the favorable comparative impact of tariff related effects of reduced direct import orders and disruption in the China market during the same period last year;
•growth in nail care due to strong consumer demand, improved replenishment orders and new and expanded distribution; and
•incremental growth from new product launches.

Segment net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $0.3 million, or 0.1%.

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Net sales revenue increased $3.5 million, or 0.8%, to $420.2 million, compared to $416.7 million. The increase was primarily driven by:
•an increase in fan, thermometer and heater sales benefitting from the favorable comparative impact of tariff related effects of cancelled or reduced direct import orders and disruption in the China market during the same period last year;
•growth in nail care due to strong consumer demand and new and expanded distribution; and
•incremental growth from new product launches.

These factors were partially offset by a decline in Beauty hair appliances and prestige hair care products primarily due to softer consumer demand, including the impact of consumer price sensitivity, continued competition, reduced replenishment orders from retail customers and lower closeout channel sales.

Segment net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $1.9 million, or 0.4%.

Consolidated Gross Profit Margin

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Consolidated gross profit margin increased 8.0 percentage points to 52.2%, compared to 44.2%. The increase in consolidated gross profit margin was primarily due to the favorable impact of tariff refunds, net of higher tariff costs, and lower overall retail trade and promotional expense year-over-year.

These factors were partially offset by inflationary product cost pressure due to commodities, fuel prices, freight, foreign currency and supply availability, and a less favorable inventory obsolescence impact year-over-year.


36

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Consolidated gross profit margin increased 3.7 percentage points to 49.2%, compared to 45.5%. The increase in consolidated gross profit margin was primarily due to the favorable impact of tariff refunds, net of higher tariff costs.

These factors were partially offset by a less favorable inventory obsolescence impact year-over-year.

Consolidated SG&A

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Consolidated SG&A ratio increased 5.4 percentage points to 46.4%, compared to 41.0%. The increase in the consolidated SG&A ratio was primarily due to:
•an increase in personnel expense, which includes investment in the organizational structure, higher incentive compensation and health insurance expense year-over-year;
•increased packaging related costs including investment in packaging redesign and packaging disposal costs to comply with extended producer responsibility (“EPR”) programs;
•divestiture litigation costs; and
•higher marketing expense, which includes incremental investments in demand creation, consumer insights, and content development.

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Consolidated SG&A ratio decreased 3.9 percentage points to 39.0%, compared to 42.9%. The decrease in the consolidated SG&A ratio was primarily due to:
•a gain on the sale of our distribution facility in Southaven, Mississippi of $54.9 million;
•the favorable comparative impact of CEO succession costs of $3.5 million recognized in the prior year period; and
•the impact of favorable operating leverage.

These factors were partially offset by:
•increased packaging related costs to comply with EPR programs;
•an increase in personnel expense, which includes investment in the organizational structure and higher incentive compensation expense year-over-year; and
•divestiture litigation costs.

Asset Impairment Charges

We did not record any asset impairment charges during the first six months of fiscal 2027. During the three months ended August 31, 2025, we recorded asset impairment charges of $326.4 million ($294.0 million after tax) to reduce our goodwill by $292.6 million and our other intangible assets by $33.8 million. During the six months ended August 31, 2025, we recorded asset impairment charges of $740.8 million ($730.1 million after tax) to reduce our goodwill by $609.6 million and our other intangible assets by $131.2 million. For additional information regarding the testing and analysis performed, see Note 5 to the accompanying condensed consolidated financial statements.

Restructuring Charges

During the three and six months ended August 31, 2026 and 2025, we incurred $2.5 million and $3.0 million, respectively, of pre-tax restructuring charges for severance and employee related costs as a result of strategic organizational changes.
37

Operating Income (Loss), Operating Margin, Adjusted Operating Income (non-GAAP) and Adjusted Operating Margin (non-GAAP) by Segment

In order to provide a better understanding of the impact of certain items on our operating income (loss), the tables that follow report the comparative pre-tax impact of asset impairment charges, CEO succession costs, divestiture litigation costs, gain on sale of distribution facility, restructuring charges, amortization of intangible assets and non-cash share-based compensation, as applicable, on operating income (loss) and operating margin for each segment and in total for the periods presented below. Adjusted operating income and adjusted operating margin may be considered non-GAAP financial measures as contemplated by SEC Regulation G, Rule 100. For additional information regarding management’s decision to present this non-GAAP financial information, see the introduction to this Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Three Months Ended August 31, 2026
(in thousands)Home & Outdoor
Beauty & Wellness
Total
Operating income (loss), as reported (GAAP)$24,067 10.6 %$(1,148)(0.5)%$22,919 5.2 %
Divestiture litigation costs— — %4,002 1.9 %4,002 0.9 %
Restructuring charges814 0.4 %1,729 0.8 %2,543 0.6 %
Subtotal24,881 10.9 %4,583 2.2 %29,464 6.7 %
Amortization of intangible assets559 0.2 %2,781 1.3 %3,340 0.8 %
Non-cash share-based compensation2,514 1.1 %2,629 1.2 %5,143 1.2 %
Adjusted operating income (non-GAAP)$27,954 12.3 %$9,993 4.7 %$37,947 8.6 %

Three Months Ended August 31, 2025
(in thousands)Home & Outdoor
Beauty & Wellness
Total
Operating loss, as reported (GAAP)
$(72,578)(34.8)%$(243,139)(109.0)%$(315,717)(73.1)%
Asset impairment charges85,537 41.0 %240,857 108.0 %326,394 75.6 %
Restructuring charges1,501 0.7 %1,504 0.7 %3,005 0.7 %
Subtotal14,460 6.9 %(778)(0.3)%13,682 3.2 %
Amortization of intangible assets1,373 0.7 %2,512 1.1 %3,885 0.9 %
Non-cash share-based compensation4,248 2.0 %5,124 2.3 %9,372 2.2 %
Adjusted operating income (non-GAAP)$20,081 9.6 %$6,858 3.1 %$26,939 6.2 %

Six Months Ended August 31, 2026
(in thousands)Home & Outdoor
Beauty & Wellness
Total
Operating income, as reported (GAAP)
$32,232 7.6 %$51,036 12.1 %$83,268 9.9 %
Divestiture litigation costs— — %4,002 1.0 %4,002 0.5 %
Gain on sale of distribution facility — — %(54,854)(13.1)%(54,854)(6.5)%
Restructuring charges814 0.2 %1,729 0.4 %2,543 0.3 %
Subtotal33,046 7.8 %1,913 0.5 %34,959 4.1 %
Amortization of intangible assets1,932 0.5 %5,563 1.3 %7,495 0.9 %
Non-cash share-based compensation5,308 1.3 %6,272 1.5 %11,580 1.4 %
Adjusted operating income (non-GAAP)$40,286 9.5 %$13,748 3.3 %$54,034 6.4 %

38

Six Months Ended August 31, 2025
(in thousands)Home & Outdoor
Beauty & Wellness
Total
Operating loss, as reported (GAAP)
$(286,371)(74.1)%$(436,384)(104.7)%$(722,755)(90.0)%
Asset impairment charges304,632 78.8 %436,147 104.7 %740,779 92.2 %
CEO succession costs1,742 0.5 %1,742 0.4 %3,484 0.4 %
Restructuring charges1,501 0.4 %1,504 0.4 %3,005 0.4 %
Subtotal21,504 5.6 %3,009 0.7 %24,513 3.1 %
Amortization of intangible assets3,155 0.8 %5,719 1.4 %8,874 1.1 %
Non-cash share-based compensation4,282 1.1 %5,386 1.3 %9,668 1.2 %
Adjusted operating income (non-GAAP)$28,941 7.5 %$14,114 3.4 %$43,055 5.4 %

Consolidated Operating Income (Loss)

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Consolidated operating income was $22.9 million, or 5.2% of net sales revenue, compared to consolidated operating loss of $315.7 million, or (73.1)% of net sales revenue. Operating loss in the second quarter of fiscal 2026 included $326.4 million of pre-tax asset impairment charges. The remaining 2.7 percentage point increase in consolidated operating margin was primarily due to:
•the favorable impact of tariff refunds, net of higher tariff costs;
•lower overall retail trade and promotional expense year-over-year; and
•the impact of favorable operating leverage.

These factors were partially offset by:
•an increase in personnel expense which includes investment in the organizational structure, higher incentive compensation and health insurance expense year-over-year;
•increased packaging related costs including investment in packaging redesign and packaging disposal costs to comply with EPR programs;
•divestiture litigation costs;
•inflationary product cost pressure due to commodities, fuel prices, freight, foreign currency and supply availability;
•higher marketing expense, which includes incremental investments in demand creation, consumer insights, and content development; and
•a less favorable inventory obsolescence impact year-over-year.

Consolidated adjusted operating income increased $11.0 million, or 40.9%, to $37.9 million, or 8.6% of net sales revenue, compared to $26.9 million, or 6.2% of net sales revenue.

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Consolidated operating income was $83.3 million, or 9.9% of net sales revenue, compared to consolidated operating loss of $722.8 million, or (90.0)% of net sales revenue. Operating loss during the first six months of fiscal 2026 included $740.8 million of pre-tax asset impairment charges. The remaining 7.7 percentage point increase in consolidated operating margin was primarily due to:
•a gain on the sale of our distribution facility in Southaven, Mississippi of $54.9 million;
•the favorable impact of tariff refunds, net of higher tariff costs;
•the favorable comparative impact of CEO succession costs of $3.5 million recognized in the prior year period; and
•the impact of favorable operating leverage.

39

These factors were partially offset by:
•increased packaging related costs to comply with EPR programs;
•an increase in personnel expense, which includes investment in the organizational structure and higher incentive compensation expense year-over-year;
•divestiture litigation costs; and
•a less favorable inventory obsolescence impact year-over-year.

Consolidated adjusted operating income increased $11.0 million, or 25.5%, to $54.0 million, or 6.4% of net sales revenue, compared to $43.1 million, or 5.4% of net sales revenue.

Home & Outdoor

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Operating income was $24.1 million, or 10.6% of segment net sales revenue, compared to operating loss of $72.6 million, or (34.8)% of segment net sales revenue. Operating loss in the second quarter of fiscal 2026 included $85.5 million of pre-tax asset impairment charges. The remaining 4.4 percentage point increase in segment operating margin was primarily due to:
•the favorable impact of tariff refunds, net of higher tariff costs; and
•the impact of favorable operating leverage.

These factors were partially offset by:
•increased packaging related costs including investment in packaging redesign and packaging disposal costs to comply with EPR programs;
•an increase in personnel expense, which includes investment in the organizational structure, higher incentive compensation and health insurance expense year-over-year;
•inflationary product cost pressure due to commodities, fuel prices, freight, foreign currency and supply availability; and
•higher marketing expense.

Adjusted operating income increased $7.9 million, or 39.2%, to $28.0 million, or 12.3% of segment net sales revenue, compared to $20.1 million, or 9.6% of segment net sales revenue.

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Operating income was $32.2 million, or 7.6% of segment net sales revenue, compared to operating loss of $286.4 million, or (74.1)% of segment net sales revenue. Operating loss during the first six months of fiscal 2026 included $304.6 million of pre-tax asset impairment charges. The remaining 2.9 percentage point increase in segment operating margin was primarily due to:
•the favorable impact of tariff refunds, net of higher tariff costs; and
•the impact of favorable operating leverage.

These factors were partially offset by:
•increased packaging related costs to comply with EPR programs; and
•an increase in personnel expense, which includes investment in the organizational structure and higher incentive compensation expense year-over-year.

Adjusted operating income increased $11.3 million, or 39.2%, to $40.3 million, or 9.5% of segment net sales revenue, compared to $28.9 million, or 7.5% of segment net sales revenue.

40

Beauty & Wellness

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Operating loss was $1.1 million, or (0.5)% of segment net sales revenue, compared to operating loss of $243.1 million, or (109.0)% of segment net sales revenue. Operating loss in the second quarter of fiscal 2026 included $240.9 million of pre-tax asset impairment charges. The remaining 0.5 percentage point increase in segment operating margin was primarily due to:
•the favorable impact of tariff refunds, net of higher tariff costs; and
•lower overall retail trade and promotional expense year-over-year.

These factors were partially offset by:
•an increase in personnel expense, which includes investment in the organizational structure higher incentive compensation and health insurance expense year-over-year;
•divestiture litigation costs;
•increased packaging related costs to comply with EPR programs;
•inflationary product cost pressure due to commodities, fuel prices, freight, foreign currency and supply availability;
•higher marketing expense;
•a less favorable inventory obsolescence impact year-over-year; and
•the impact of unfavorable operating leverage.

Adjusted operating income increased $3.1 million, or 45.7%, to $10.0 million, or 4.7% of segment net sales revenue, compared to $6.9 million, or 3.1% of segment net sales revenue.

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Operating income was $51.0 million, or 12.1% of segment net sales revenue, compared to operating loss of $436.4 million, or (104.7)% of segment net sales revenue. Operating loss during the first six months of fiscal 2026 included $436.1 million of pre-tax asset impairment charges. The remaining 12.1 percentage point increase in segment operating margin was primarily due to:
•a gain on the sale of our distribution facility in Southaven, Mississippi of $54.9 million; and
•the favorable impact of tariff refunds, net of higher tariff costs.

These factors were partially offset by:
•divestiture litigation costs;
•a less favorable inventory obsolescence impact year-over-year;
•higher marketing expense;
•an increase in personnel expense, which includes investment in the organizational structure and higher incentive compensation expense; and
•increased packaging related costs to comply with EPR programs.

Adjusted operating income decreased $0.4 million, or 2.6%, to $13.7 million, or 3.3% of segment net sales revenue, compared to $14.1 million, or 3.4% of segment net sales revenue.

Interest Expense

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Interest expense was $10.9 million, compared to $14.2 million. The decrease in interest expense was primarily due to lower average borrowings outstanding and a lower average effective interest rate, inclusive of the impact of our interest rate swaps, compared to the same period last year.

41

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Interest expense was $23.1 million, compared to $28.0 million. The decrease in interest expense was primarily due to lower average borrowings outstanding compared to the same period last year.

Income Tax Expense

The comparison of our effective tax rate between periods is often impacted by the geographic mix of earnings among our various tax jurisdictions. Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intangible assets are primarily owned by foreign affiliates, generally resulting in proportionally higher earnings in jurisdictions with statutory tax rates lower than that of the U.S.

For interim periods, our income tax expense and resulting effective tax rate are based on an estimated annual effective tax rate, adjusted for the impact of discrete items recognized in the period. Jurisdictions with year-to-date or forecasted losses for which a tax benefit cannot be recognized are excluded from the estimated annual effective tax rate calculation, which may increase the effective tax rate in interim periods.

Discrete items are recognized in the period in which they occur and include changes in tax laws or rates, changes in estimates for uncertain tax positions, excess tax benefits or deficiencies from stock-based compensation, foreign currency remeasurement effects that cannot be reasonably estimated as part of the annual effective tax rate, and other infrequent or non-recurring items. Discrete items do not include the asset impairment charges described below and in Note 5 to the accompanying condensed consolidated financial statements.

During the three and six months ended August 31, 2025, we recognized goodwill and other intangible asset impairment charges of $326.4 million and $740.8 million, respectively, which included $246.0 million and $511.0 million, respectively, of non-deductible goodwill that did not result in a tax benefit. The tax benefit on the impairment charge was recognized over the course of fiscal 2026 in relation to pre-tax book income, rather than as a discrete item in the periods in which the charges were incurred.

The downward revisions to our internal forecasts utilized in our impairment testing during the first half of fiscal 2026 impacted our assessment of the future realizability of a related deferred tax asset, which led to the recording of discrete valuation allowances of $13.5 million and $30.0 million during the three and six months ended August 31, 2025, respectively.

For the three months ended August 31, 2026, income tax expense was $9.2 million on pre-tax income of $13.8 million, compared to an income tax benefit of $21.0 million on a pre-tax loss of $329.7 million for the same period last year. The increase in income tax expense and effective tax rate was primarily due to an increase in jurisdictions with losses excluded from the estimated annual effective tax rate calculation in fiscal 2027, and was also affected by impairment charges and the timing of related tax effects and deferred tax asset valuation allowances recognized in the same period last year.

For the six months ended August 31, 2026, income tax expense was $21.7 million on pre-tax income of $62.1 million, compared to income tax expense of $9.1 million on a pre-tax loss of $750.2 million for the same period last year. The increase in income tax expense and effective tax rate was primarily due to income tax expense recognized on the gain from the sale of our distribution facility in Southaven, Mississippi and an increase in jurisdictions with losses excluded from the estimated annual effective tax rate calculation in fiscal 2027, and was also affected by impairment charges and the timing of related tax effects and deferred tax asset valuation allowances recognized in the same period last year.
42

Net Income (Loss), Diluted Earnings (Loss) Per Share, Adjusted Income (non-GAAP) and Adjusted Diluted Earnings Per Share (non-GAAP)

In order to provide a better understanding of the impact of certain items on our income (loss) and diluted earnings (loss) per share, the tables that follow report the comparative after-tax impact of asset impairment charges, CEO succession costs, divestiture litigation costs, gain on sale of distribution facility, intangible asset reorganization, restructuring charges, amortization of intangible assets and non-cash share-based compensation, as applicable, on income (loss) and diluted earnings (loss) per share for the periods presented below. Adjusted income and adjusted diluted earnings per share may be considered non-GAAP financial measures as contemplated by SEC Regulation G, Rule 100. For additional information regarding management’s decision to present this non-GAAP financial information, see the introduction to this Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Three Months Ended August 31, 2026
Income Diluted Earnings Per Share
(in thousands, except per share data)Before TaxTaxNet of TaxBefore TaxTaxNet of Tax
As reported (GAAP)$13,788 $9,156 $4,632 $0.57 $0.38 $0.19 
Divestiture litigation costs4,002 — 4,002 0.17 — 0.17 
Restructuring charges2,543 — 2,543 0.11 — 0.11 
Subtotal20,333 9,156 11,177 0.84 0.38 0.46 
Amortization of intangible assets3,340 451 2,889 0.14 0.02 0.12 
Non-cash share-based compensation5,143 212 4,931 0.21 0.01 0.20 
Adjusted (non-GAAP)$28,816 $9,819 $18,997 $1.19 $0.41 $0.79 
Weighted average shares of common stock used in computing reported and non-GAAP diluted earnings per share24,153 

Three Months Ended August 31, 2025
(Loss) IncomeDiluted (Loss) Earnings Per Share
(in thousands, except per share data)Before TaxTaxNet of TaxBefore TaxTaxNet of Tax
As reported (GAAP)$(329,689)$(21,046)$(308,643)$(14.36)$(0.92)$(13.44)
Asset impairment charges326,394 32,419 293,975 14.18 1.41 12.77 
Intangible asset reorganization— (13,485)13,485 — (0.59)0.59 
Restructuring charges3,005 421 2,584 0.13 0.02 0.11 
Subtotal(290)(1,691)1,401 (0.01)(0.07)0.06 
Amortization of intangible assets3,885 669 3,216 0.17 0.03 0.14 
Non-cash share-based compensation9,372 445 8,927 0.41 0.02 0.39 
Adjusted (non-GAAP)$12,967 $(577)$13,544 $0.56 $(0.03)$0.59 
Weighted average shares of common stock used in computing:
Diluted loss per share, as reported22,959 
Adjusted diluted earnings per share (non-GAAP)23,012 
43

Six Months Ended August 31, 2026
IncomeDiluted Earnings Per Share
(in thousands, except per share data)Before TaxTaxNet of TaxBefore TaxTaxNet of Tax
As reported (GAAP)$62,112 $21,718 $40,394 $2.59 $0.91 $1.69 
Divestiture litigation costs4,002 — 4,002 0.17 — 0.17 
Gain on sale of distribution facility(54,854)(13,549)(41,305)(2.29)(0.57)(1.72)
Restructuring charges2,543 — 2,543 0.11 — 0.11 
Subtotal13,803 8,169 5,634 0.58 0.34 0.24 
Amortization of intangible assets7,495 1,123 6,372 0.31 0.05 0.27 
Non-cash share-based compensation11,580 636 10,944 0.48 0.03 0.46 
Adjusted (non-GAAP)$32,878 $9,928 $22,950 $1.37 $0.41 $0.96 
Weighted average shares of common stock used in computing reported and non-GAAP diluted earnings per share23,956 

Six Months Ended August 31, 2025
(Loss) Income Diluted (Loss) Earnings Per Share
(in thousands, except per share data)Before TaxTaxNet of TaxBefore TaxTaxNet of Tax
As reported (GAAP)$(750,227)$9,134 $(759,361)$(32.69)$0.40 $(33.09)
Asset impairment charges
740,779 10,650 730,129 32.22 0.46 31.76 
CEO succession costs
3,484 153 3,331 0.15 0.01 0.14 
Intangible asset reorganization
— (29,959)29,959 — (1.30)1.30 
Restructuring charges3,005 421 2,584 0.13 0.02 0.11 
Subtotal(2,959)(9,601)6,642 (0.13)(0.42)0.29 
Amortization of intangible assets8,874 1,551 7,323 0.39 0.07 0.32 
Non-cash share-based compensation9,668 602 9,066 0.42 0.03 0.39 
Adjusted (non-GAAP)$15,583 $(7,448)$23,031 $0.68 $(0.32)$1.00 
Weighted average shares of common stock used in computing:
Diluted loss per share, as reported22,951 
Adjusted diluted earnings per share (non-GAAP)22,992 

Comparison of Second Quarter Fiscal 2027 to Second Quarter Fiscal 2026
Net income was $4.6 million, compared to net loss of $308.6 million. Diluted earnings per share was $0.19, compared to diluted loss per share of $13.44. The increase is primarily due to the comparative impact of after-tax asset impairment charges of $294.0 million and valuation allowances on deferred tax assets related to our intangible asset reorganization both recognized during the second quarter of fiscal 2026, higher operating income exclusive of asset impairment charges and a decrease in interest expense. These impacts were partially offset by higher income tax expense.

Adjusted income increased $5.5 million, or 40.3%, to $19.0 million, compared to $13.5 million. Adjusted diluted earnings per share increased 33.9% to $0.79, compared to $0.59.

44

Comparison of First Six Months of Fiscal 2027 to First Six Months of Fiscal 2026
Net income was $40.4 million, compared to net loss of $759.4 million. Diluted earnings per share was $1.69, compared to diluted loss per share of $33.09. The increase is primarily due to the comparative impact of after-tax asset impairment charges of $730.1 million and valuation allowances on deferred tax assets related to our intangible asset reorganization both recognized during the first six months of fiscal 2026, the recognition of an after-tax gain on the sale of our distribution facility of $41.3 million during the first quarter of fiscal 2027, higher operating income exclusive of the aforementioned items and a decrease in interest expense. These impacts were partially offset by higher income tax expense.

Adjusted income was $23.0 million for both the six months ended August 31, 2026 and 2025. Adjusted diluted earnings per share decreased 4.0% to $0.96, compared to $1.00.

Liquidity and Capital Resources

We principally rely on our cash flow from operations and borrowings under our Credit Agreement (as defined below) to finance our operations, capital and intangible asset expenditures, acquisitions and share repurchases. Historically, our principal uses of cash to fund our operations have included operating expenses, primarily SG&A, and working capital, predominantly for inventory purchases and the extension of credit to our retail customers. We have typically been able to generate positive cash flow from operations sufficient to fund our operating activities. In the past, we have utilized a combination of available cash and existing, or additional, sources of financing to fund strategic acquisitions, share repurchases and capital investments. We generated $56.5 million in cash from operations during the first six months of fiscal 2027 and had $22.6 million in cash and cash equivalents at August 31, 2026. As of August 31, 2026, the amount of cash and cash equivalents held by our foreign subsidiaries was $18.1 million. We have no existing activities involving special purpose entities or off-balance sheet financing.

We believe our short-term liquidity requirements will primarily consist of operating and working capital requirements, capital expenditures and interest payments on our debt. Based on our current financial condition and current operations, we believe that cash flows from operations and available financing sources will continue to provide sufficient capital resources to fund our foreseeable short- and long-term liquidity requirements. In the short-term we plan to prioritize repaying our debt outstanding.

Operating Activities

Operating activities provided net cash of $56.5 million for the six months ended August 31, 2026, compared to net cash provided of $47.9 million for the same period last year. The increase in cash provided by operating activities was primarily driven by an increase in cash earnings and decreases in payments for inventory, inclusive of tariffs, and interest, partially offset by increases in cash used primarily for accounts receivable, annual incentive compensation and income taxes.

Investing Activities

Investing activities provided net cash of $60.3 million during the six months ended August 31, 2026, compared to net cash used of $21.0 million for the same period last year. The increase in cash provided by investing activities was primarily due to proceeds received from the sale of our distribution facility in Southaven, Mississippi and a decrease in capital and intangible asset expenditures.

Financing Activities

Financing activities used net cash of $113.0 million during the six months ended August 31, 2026, compared to net cash used of $23.4 million for the same period last year. The increase in cash used by
45

financing activities is primarily due to net repayments of our long-term debt of $109.0 million and a $4.1 million contingent consideration payment related to the Olive & June acquisition during the first six months of fiscal 2027, in comparison to net repayments of long-term debt of $23.2 million during the same period last year.

Credit Agreement

We have an amended credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for aggregate commitments of $1.25 billion, which are available through (i) a $750 million revolving credit facility, which includes a $50 million sublimit for the issuance of letters of credit, (ii) a $250 million term loan facility, and (iii) a $250 million delayed draw term loan facility. Proceeds can be used for working capital and other general corporate purposes, including funding permitted acquisitions. During the first quarter of fiscal 2026, we borrowed $250.0 million under the delayed draw term loan facility and utilized the proceeds to repay debt outstanding under the revolving credit facility. During the first quarter of fiscal 2026, we capitalized $0.4 million of lender fees and a de minimis amount of third-party fees incurred in connection with the delayed draw term loan facility borrowing, which were recorded as prepaid financing fees in long-term debt. The Credit Agreement matures on February 15, 2029. The Credit Agreement includes an accordion feature, which permits the Company to request to increase its borrowing capacity by an additional $300 million plus an unlimited amount when the Leverage Ratio (as defined in the Credit Agreement), on a pro-forma basis, is less than 3.25 to 1.00. The term loans and delayed draw term loans are currently payable at the end of each fiscal quarter in equal installments of 1.25% of the original principal balance, with the remaining balance due at the maturity date. Borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR (as defined in the Credit Agreement), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.375% and 1.0% to 2.375% for Base Rate and Term SOFR borrowings, respectively. We also incur loan commitment and letter of credit fees under the Credit Agreement ranging from 0.1% to 0.45% per annum and 1.0% to 2.375% per annum, respectively, based on our Net Leverage Ratio.

The floating interest rates on our borrowings under the Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $300 million and $325 million of the outstanding principal balance under the Credit Agreement as of August 31, 2026 and February 28, 2026, respectively. For additional information regarding our interest rate swaps, see Notes 10, 11, and 12 to the accompanying condensed consolidated financial statements.

As of August 31, 2026, the outstanding Credit Agreement principal balance was $676.5 million (excluding prepaid financing fees) and the balance of outstanding letters of credit was $9.5 million. As of August 31, 2026, the amount available for revolving loans under the Credit Agreement was $528.8 million, and the amount available per the maximum Leverage Ratio was $277.3 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As of August 31, 2026, these covenants effectively limited our ability to incur more than $277.3 million of additional debt from all sources, including the Credit Agreement.

Debt Covenants

As of August 31, 2026, we were in compliance with all covenants as defined under the terms of the Credit Agreement.

46

Critical Accounting Policies and Estimates

The SEC defines critical accounting estimates as those made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on a company’s financial condition or results of operations. For a discussion of the estimates that we consider to meet this definition and represent our more critical estimates and assumptions used in the preparation of our consolidated financial statements, see the section entitled “Critical Accounting Policies and Estimates” in our Form 10-K. Since the filing of our Form 10-K, there have been no material changes in our critical accounting policies and estimates from those disclosed therein.
47

Information Regarding Forward-Looking Statements

Certain statements in this report, including those in documents and our other filings with the SEC referenced herein, may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. Generally, the words “anticipates”, “assumes”, “believes”, “expects”, “plans”, “may”, “will”, “might”, “would”, “should”, “seeks”, “estimates”, “project”, “predict”, “potential”, “currently”, “continue”, “intends”, “outlook”, “forecasts”, “targets”, “reflects”, “could”, and other similar words identify forward-looking statements. All statements that address operating results, events or developments that we expect or anticipate may occur in the future, including statements related to sales, expenses, earnings per share results, and statements expressing general expectations about future operating results, are forward-looking statements and are based upon our current expectations and various assumptions. We currently believe there is a reasonable basis for our expectations and assumptions, but there can be no assurance that we will realize our expectations or that our assumptions will prove correct. Forward-looking statements are only as of the date they are made and are subject to risks, many of which are beyond our control, that could cause them to differ materially from actual results. Accordingly, we caution readers not to place undue reliance on forward-looking statements. We believe that these risks include but are not limited to the risks described or referenced in this report and that are otherwise described from time to time in our SEC reports as filed. We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

Such risks are not limited to, but may include:
•the geographic concentration of certain U.S. distribution facilities which increases our risk to disruptions that could affect our ability to deliver products in a timely manner;
•the occurrence of cyber incidents or failure by us or our third-party service providers to maintain cybersecurity and the integrity of confidential internal or customer data;
•a cybersecurity breach, obsolescence or interruptions in the operation of our central global Enterprise Resource Planning systems and other peripheral information systems;
•the risks associated with the use of licensed trademarks from or to third parties;
•our ability to develop and introduce a continuing stream of innovative new products to meet changing consumer preferences;
•actions taken by large customers that may adversely affect our gross profit and operating results;
•our dependence on sales to several large customers and the risks associated with any loss of, or substantial decline in, sales to top customers;
•our dependence on third-party manufacturers, most of which are located in Asia, and any inability to obtain products from such manufacturers or diversify production to other regions or source the same product in multiple regions or implement potential tariff mitigation plans;
•our ability to deliver products to our customers in a timely manner and according to their fulfillment standards;
•the risks associated with trade barriers, exchange controls, expropriations, and other risks associated with domestic and foreign operations including uncertainty and business interruptions resulting from political changes and events in the U.S. and abroad, and volatility in the global credit and financial markets and economy;
•our dependence on the strength of retail economies and vulnerabilities to any prolonged economic downturn, including a downturn from the effects of macroeconomic conditions, geopolitical conditions including global conflicts or wars such as the Israel-United States and Iran conflict, any public health crises or similar conditions;
•the risks associated with weather conditions, the duration and severity of the cold and flu season and other related factors;
•our reliance on our CEO and a limited number of other key senior officers to operate our business;
•our ability to execute and realize expected synergies from strategic business initiatives such as acquisitions, divestitures and global restructuring plans;
48

•the risks of significant tariffs or other restrictions continuing to be placed on imports from China, Vietnam or Mexico and any retaliatory measures taken by these countries;
•the risks of potential changes in laws and regulations, including environmental, employment and health and safety and tax laws, and the costs and complexities of compliance with such laws;
•the risks associated with increased focus and expectations on climate change and other sustainability matters;
•the risks associated with significant changes in or our compliance with regulations, interpretations or product certification requirements;
•the risks associated with global legal developments regarding privacy and data security that could result in changes to our business practices, penalties, increased cost of operations, or otherwise harm our business;
•the risks associated with product recalls, product liability, class actions and other claims against us;
•our dependence on whether we are classified as a “controlled foreign corporation” for U.S. federal income tax purposes which impacts the tax treatment of our non-U.S. income;
•the risks associated with regulatory changes in Bermuda, including economic substance and tax governance requirements;
•the risks associated with accounting for tax positions and the resolution of tax disputes;
•associated financial risks including but not limited to, the risks to our business, liquidity or cost of capital which may be materially adversely affected by constraints or changes in the capital and credit markets, interest rates and limitations under and compliance with our credit facility, including our debt covenants;
•significant additional impairment of our goodwill, indefinite-lived and definite-lived intangible assets and other long-lived assets;
•projections of product demand, sales and net income, which are highly subjective in nature, and which future sales and net income could vary by a material amount;
•increased costs of raw materials, energy and transportation; and
•the risks associated with foreign currency exchange rate fluctuations.
49

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in the information provided in the section entitled “Quantitative and Qualitative Disclosures About Market Risk” in our Form 10-K. Additional information regarding our risk management activities can be found in Notes 9, 10 and 11 to the accompanying condensed consolidated financial statements.

ITEM 4. CONTROLS AND PROCEDURES

Based on their evaluation, as of the end of the period covered by this Quarterly Report on Form 10-Q, our Company’s Chief Executive Officer and Chief Financial Officer have concluded that our Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) are effective at the reasonable assurance level. During the period covered by this Quarterly Report on Form 10-Q, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS 

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described in Part I, Item 3., “Legal Proceedings” of our Form 10-K. Since the filing of our Form 10-K, there have been no material changes in our legal proceedings from those disclosed therein, except as updated herein in the discussion in Note 8 to the accompanying condensed consolidated financial statements.

ITEM 1A. RISK FACTORS

The ownership of our common stock involves a number of risks and uncertainties. When evaluating the Company and our business before making an investment decision regarding our securities, potential investors should carefully consider the risk factors and uncertainties described in Part I, Item 1A., “Risk Factors” of our Form 10-K. Since the filing of our Form 10-K, there have been no material changes in our risk factors from those disclosed therein.

50

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

In August 2024, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 20, 2024, for a period of three years, and replaced our former repurchase authorization. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. See Note 7 to the accompanying condensed consolidated financial statements for additional information.

Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes and federal withholding taxes due from the share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as repurchases of shares.

The following table summarizes our share repurchase activity for the periods shown:
PeriodTotal Number
of Shares 
Purchased (1)		Average Price
Paid per Share		Total Number of
Shares Purchased as Part of Publicly
Announced Plans
or Programs (1)		Maximum Dollar 
Value of Shares 
that May Yet be 
Purchased Under the 
Plans or Programs
(in thousands) (2)
June 1 through June 30, 20267 $26.66 7 $496,798 
July 1 through July 31, 20261,651 28.35 1,651 496,751 
August 1 through August 31, 2026— — — 496,751 
Total1,658 $28.35 1,658 
(1)The number of shares includes shares of common stock acquired from associates who tendered shares to satisfy the tax withholding on equity awards as part of our long-term incentive plans. For the periods presented, there were no common stock open market repurchases.
(2)Reflects the remaining dollar value of shares that could be purchased under our current stock repurchase authorization through the expiration or termination of the plan. For additional information, see Note 7 to the accompanying condensed consolidated financial statements.



ITEM 5. OTHER INFORMATION

Rule 10b5-1 Trading Plans

During the three months ended August 31, 2026, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”



51

Table of Contents
ITEM 6.EXHIBITS
(a)Exhibits
101
Financial statements from the Quarterly Report on Form 10-Q of the Company for the quarter ended August 31, 2026, formatted in Inline eXtensible Business Reporting Language (“iXBRL”): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income (Loss), (iii) Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows and (vi) Notes to the Condensed Consolidated Financial Statements.
104Cover Page, Interactive Data File formatted in iXBRL and contained in Exhibit 101.
*     Filed herewith.

**   Furnished herewith.
† Management contract or compensatory plan or arrangement.

52

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

HELEN OF TROY LIMITED
(Registrant)
Date:October 8, 2026
  /s/ G. Scott Uzzell
G. Scott Uzzell
Chief Executive Officer and Director
(Principal Executive Officer)
Date:
October 8, 2026
/s/ Brian L. Grass
Brian L. Grass
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)

53

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com